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SMALL SCALE SERVICE RELATED PROJECT
Evaluation of an Opt-in System in Primary Care
Target Journal: Clinical Psychology Forum 
(see Appendix 1 for Submission Notes)
Evaluation of an opt-in system in primary care
INTRODUCTION
Non-attendance of patients has long been an issue for clinical psychologists. Various 
authors have associated it with decreased therapist morale (Hughes, 1995) and wasted 
therapist time (Startup, 1994), time that could be used to decrease the lengthy waiting 
lists which burden most psychology services (DCP, 1993).
Non-attendance and early treatment terminations are estimated to account for between 
25 and 40 per cent of all outpatients referred to clinical psychology services (Markman 
and Beeney,1990; Trepka,1986, respectively). Hughes (1995) estimates that, in British 
clinical psychology services, approximately one third of patients terminate treatment 
early. First appointment non-attendance predicts a likelihood of subsequent second 
appointment non-attendance (Weighill, Hodge and Peck, 1983). A potentially effective 
method of increasing first appointment attendance is to ask patients to "opt-in" to 
treatment. Anderson and White (1995) found the use of an opt-in system in primary 
care clinics decreased the first appointment "did not attend" (DNA) rates from 25 to 3 
per cent. Another promising method is to prepare patients for psychological input by 
providing information about the role of the psychologist and the service they provide. 
Webster (1992) found the use of information leaflets at a day centre psychology service 
reduced first appointment DNAs from 43 to 18 per cent and also improved patient 
satisfaction with the session itself. Spector (1988) reported that combination of opt-in 
system and information leaflets reduced a first appointment DNA rate from 35 to 12 per 
cent.
The present study aimed to evaluate a system of opt-in and information provision in 
reducing first appointment DNAs in comparison with a similar primary care clinic 
without an opt-in system, i.e. with a "conventional" referral system.
2
The Renfrewshire Clinical Psychology Department was requested to set up a special 
primary care service funded directly by the Scottish Office. It was to run in a town 
which had not previously had a local primary care psychology service. The funding was 
initially for one year only and it was deemed the ideal opportunity to pilot a new system 
of referral in which the GP was involved with both information provision and an opt-in 
system. In this system the GP gave the potential clinical psychology patient an 
information leaflet and a "consultation request form”. The information leaflet was 
entitled “The Bishopton Stress Clinic” and contained information under the headings: 
who can be helped, what kind of help patients might receive, results of treatment, 
patient involvement, what is a clinical psychologist, and how to get, cancel and change 
appointments. The consultation request form simply required the patient to fill in 
sections giving their name, address and signature. It also allowed them to add some 
information about their problem, should they wish. The GP also explained briefly why 
a referral to the clinical psychologist might be of benefit. Next the patient was required 
to fill in the request form and return it to their GP in their own time, it was then sent by 
the GP, with a covering referral letter, to the clinical psychology department. On 
receipt of the referral letter and completed form, the patient was then placed on the 
waiting list and was usually seen within the next three or four weeks.
METHODOLOGY
As this service was new, it was not possible to compare the DNA rates of the group 
using the opt-in system with data prior to the introduction of the system, as has been 
done by other authors (e.g. Anderson and White, 1995). Instead it was necessary to find 
a similar primary care service with which to make the comparison. This was not 
feasible within the department as the new service had a minimal waiting list whereas 
other department primary care clinics had relatively long waiting lists. As waiting list 
length is likely to be linked with increased first appointment DNAs (Anderson and 
White, 1995), it was necessary to obtain data from a different Clinical Psychology 
Department. It was hoped that in this way a comparative group could be found, i.e. a 
group with similar waiting times and similar sociodemographics, but without any form 
of opt-in system (the conventional referral group).
The opt-in group consisted of 61 referrals from the 12 month period (July 1995 to June 
1996) to the new clinic in Renfrewshire. The conventional referral group consisted of 
115 referrals from a three year period (March 1993 to March 1996) to a primary care 
clinic in Ayrshire (a longer time period was used to give a larger number and thus allow 
for more robust statistical comparisons to be made). All patients were between the ages 
of 16 and 65 inclusive. All were first referrals to the psychology service. The two areas 
were also considered to be similar enough in socio-economic terms. According to the 
most recent census data (Crown census, 1991), the opt-in group had a three per cent 
unemployment rate and the conventional referral group had a four per cent 
unemployment rate (where "unemployment" is defined as claiming unemployment 
benefit only and does not include those claiming income support, disability allowance 
or retired individuals).
For each patient, data was collected on age, sex, waiting time and diagnosis or "reason 
for referral". This last variable was used to assess whether GPs in both areas were 
referring similar types of problem. The coding system used was that of the 
Renfrewshire psychology department, and for the purposes of analysis, coding of 
problems was condensed into three simple categories: (1) anxiety disorders (i.e. 
generalised anxiety disorder, panic attacks, phobias, post traumatic stress disorder and 
obsessive compulsive disorder, as grouped by the DSM-IV, 1994); (2) depression; and, 
(3) "other", essentially non-affective disorders (such as grief, eating disorders and 
neuropsychological assessment)
RESULTS
Comparison o f  opt-in sample and conventional referral sample
Age, sex, waiting times and reason for referral for each of the two groups are described
in table 1.
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Insert Table I. About Here
Independent t-tests showed that there were no significant difference between groups for 
waiting time (t =1.05, d f=174, p = n.s.) or age (t =1.05, d f=174, p = n.s.). Chi-square 
test on sex and reason for referral also demonstrated no significant differences between 
the groups (x2=1.146, d f=1, p = n.s.; x2==0-399, df =2, p = n.s., respectively).
Thus the two groups were noted to have very similar mean ages and age ranges. Both 
groups had greater numbers of women referred than men. Waiting time means also 
appeared similar although the conventional referral group had a more variable range of 
waiting times. Both groups had very similar percentages of anxiety disorders, 
depression and "other" reasons for referral
The above analysis demonstrated that the selected conventional referral group was 
similar to the opt-in group. This allows a comparison of DNA rates between the two 
referral systems to be completed. See table 2.
Insert Table 2. About Here
Defining "contact" as either attending or cancelling an appointment, there was no 
significant difference between groups (group (x2=0.034, d f=1, p = n.s.). Defining 
"attendance" as attending an appointment, i.e. neither cancelling nor DNAing, again no 
significant difference was found between the groups (x2==0.537, d f=1, p = n.s.).
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DISCUSSION
The results of this study indicated that the opt-in system group was not significantly 
different from the conventional referral system group in terms of frequency of first 
appointment DNAs.
Why did the opt-in system not decrease DNA rates?
As mentioned in the introduction, previous studies have supported the efficacy of opt-in 
systems in reducing first appointment DNA rate (Anderson and White, 1995; Spector, 
1988). However, Markman and Beeney (1990) found that an opt-in system did not 
affect first appointment DNA rates. Perhaps the reason for this discrepancy between 
the above studies is due, in part, to first appointment DNA rates prior to an opt-in 
system being introduced. Anderson and White (1995) found this to be 25 per cent and, 
Spector (1988), 35 per cent. However, Markman and Beeney (1990) noted a DNA rate 
of only 15 per cent before the opt-in system was introduced. In the present study, the 
conventional referral group had first appointment DNA rate of only 7.4 per cent.
Such a low DNA rate suggests that the conventional referral group used in this study 
may be different from the groups reported in previous studies. The comparison group 
in this study was obtained from a trading agency. This factor may have played some 
part in the low DNA rate observed in this group. Perhaps, because the trading agency 
had recently formed and had been in contact with many local GPs to explain their role, 
referrals may have been more appropriate. The agency certainly emphasised the 
importance of providing an acceptable service to GPs and had contracted to stay within 
an average waiting time of nine weeks. It is possible that these actions made local GPs 
more “psychologically aware” and thus they made more appropriate referrals, which 
might have resulted in greater first appointment attendance.
In both groups patients waited for approximately four weeks before being seen. It 
would appear that both the opt-in and the conventional groups had shorter waiting times 
than the norm (DCP, 1993). Geekie (1995) reported a typical primary care waiting list 
as being 15 weeks and the DCP report (1993) noted the most common waiting time 
nationally to be 17 to 26 weeks. In the Anderson and White study, waiting time was 26
6
weeks. It is suggested that, if a patient has to wait a long time for a first appointment, 
their situation might change in a number of ways, which might affect whether they 
attend their first appointment. For example, their problem may have improved during 
the wait, they may have gained help or support from other sources or they may have lost 
motivation, resulting in their not wishing intervention.
Also, both groups in the present study appeared to have come from areas of relatively 
low unemployment and, by implication, higher socio-economic status. Weighill, Hodge 
and Peck (1983) noted that socio-economic status was related to broken appointments 
and self-termination of treatment.
So when would an opt-in system be o f  use?
From the literature and from the above results, there would appear to be times when the 
use of an opt-in system would be especially efficient. In particular, it seems that such a 
system might be of much benefit when;
1. waiting lists are long,
2. DNA rates are high,
3. clinics cover areas with higher levels of deprivation.
Any combination of these three factors might warrant an opt-in system. When waiting 
lists are short (e.g. less than six weeks), there may be no advantage in using an opt-in 
system.
CONCLUSION
In certain services and clinics, opt-in systems may be very effective in reducing first 
appointment DNA rates. However, an opt-in system may not be necessary when 
waiting times are short and DNA rates are low. An opt-in system is an additional 
administrative burden and this hidden cost cannot be ignored. Nevertheless, opt-in 
systems such as the one used in this study, may be less of a burden than clinical 
psychology driven opt-in systems due to the extent of GP involvement.
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Table 1: Comparison o f samples: Age, sex, waiting times and reason for referral
Opt-in referral 
system
Conventional 
referral system
Age (years) mean 39.03 37.09
range 17-63 17-64
Sex (%) males 39.3 31.3
females 60.7 68.7
Waiting time (weeks) mean 4.34 3.92
range 1 -8 0 -1 4
Reason for referral (%) anxiety 57.4 55.2
depression 23.0 21.0
“other” 19.7 23.8
Table 2: Attendance at first appointment: Opt-in system v conventional referral system
First appointment Opt-in referral
system
Conventional 
referral system
Attended n ( 52 (85.2) 87 (80.6)
Cancelled n (%) 4 (6.6) 13 (12.0)
DNA (no contact) n ( 5 (8.2) 8 (7.4)
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Activity, Fatigue and Mood in Chronic Fatigue Syndrome: A 
Review
Abstract - The role ofpsychological and behavioural factors in the aetiology and 
symptomatology o f chronic fatigue syndrome (CFS) has recently been recognised in the 
literature. Theoretical models o f  CFS emphasise that activity levels, perception o f  
fatigue and low mood are important in this syndrome. Studies o f  these three factors in 
CFS are therefore reviewed, and it is suggested that much o f  the past literature in this 
area has used experimental designs and methods which have yielded contradictory 
findings. In particular, several studies have used retrospective, self-report measures o f  
activity, which have been found to be unreliable in this patient group. The use o f  
concurrent, subjective ratings and objective measurements o f  the factors is suggested 
for future research. This approach also allows diurnal variability o f  the factors to be 
investigated, which is fe lt to be another important but under-researched area in CFS.
Keywords: Activity; Chronic fatigue syndrome; Fatigue; Mood.
INTRODUCTION
Chronic fatigue syndrome (CFS) is a condition defined, most prominently, by the 
presence of persistent and disabling fatigue which is out of proportion with the 
sufferer’s level of activity or exertion. Fukuda, Straus, Hickie et al. (1), from the 
American Centre for Disease Control, define the condition by the presence of fatigue 
lasting for six or more consecutive months for which no other underlying or 
contributing medical or psychiatric condition can be found. In addition, four or more of 
the following symptoms must be present for six months or more: impaired memory or 
concentration, sore throat, tender lymph nodes, muscle pain, joint pain, headaches, un- 
refreshing sleep, and post-exertion malaise. Another operational definition, 
recommended by the Royal Colleges of Physicians, Psychiatrists and General 
Practitioners, is that proposed by Sharpe, Archard, Banatvala et al. (2). This definition
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focuses on similar criteria to that of Fukuda et al. and also provides guidelines for 
research. Prior to 1991 other definitions of CFS existed which, in clinical terms, were 
more than satisfactory. However, as research criteria they were a little broader than has 
been recommended recently, thus the methodology of earlier research should be viewed 
cautiously.
Since CFS has only relatively recently been acknowledged as a disorder by medical and 
allied professions, it is surprising how prevalent it is currently thought to be. Using the 
recommended criteria above, the population point prevalence of CFS is estimated to be 
approximately 0.6 per cent in primary care (3).
Theories o f the aetiology and pathogenesis o f CFS
Numerous theories regarding the aetiology and pathology of CFS have been suggested 
over the last ten years or so, though few of these have been convincingly supported by 
the literature. These theories have included:
1. Viral infections as a cause (4 ,5 ,6) or a trigger (7) for CFS.
2. Muscle dysfunction as the cause of fatigue (8,9,10).
3. Immune system depression (11,12,13,14) or activation (15) as a cause.
4. Neuro-anatomical (16) or neuro-endocrinological (17,18) changes resulting in 
fatigue.
5. Psychological difficulties (19,20,21) presenting as a fatigue syndrome.
As noted in the report by the National Task Force on CFS (22), “Chronic fatigue 
syndromes often do not fit neatly into the conventional view that disease is either 
physical or psychological” (p. 2).
The report of a joint working group of the Royal Colleges of Physicians, Psychiatrists 
and General Practitioners (23) notes as part of its conclusion:
“There is no evidence that infections have a primary causal role in the vast 
majority o f  cases, although they appear to precipitate the disorder in some. Previous 
personality factors and premorbid distress appear to be more important than common 
viral infection per se. They may also play an important part in perpetuating disability.
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“The evidence fo r  structural or functional abnormalities o f  brain or muscle or 
fo r a disturbance o f  endocrine or immune function as primary aetiological factors in 
CFS is currently weak." (p. 37)
Thus the report emphasises and acknowledges the large part played by psychological 
factors in the symptomatology of CFS.
It is the intention of this review to investigate the literature relating to activity levels, 
perceptions of fatigue and low mood in sufferers of CFS. Few studies simultaneously 
address these specific aspects of the CFS experience, as a consequence, the literature 
regarding important theoretical models of CFS will be reviewed initially, followed by 
the literature on each separate factor. Finally, the few papers which address these or 
similar variables simultaneously will be discussed
COGNITIVE BEHAVIOURAL MODELS OF CFS
Wessley, David, Butler and Chalder (24) theorised that a number of factors interact in 
CFS, perpetuating and maintaining symptoms. These include; patients’ beliefs of 
physical illness, resultant decreases in activity, which lead to deconditioning, and 
depression, with its concomitant behaviours. They postulated the existence of a vicious 
circle in which the CFS sufferers attributed all their symptoms to a disease and avoided 
activity in order to avoid symptoms, thereby exacerbating both depression and 
deconditioning and hence increasing fatigue and weakness and perpetuating symptoms.
This theory was further developed by Surawy, Hackmann, Hawton and Sharpe (25). 
They identified the key clinical features of CFS as coming under the headings of; 
symptoms, illness beliefs, behaviour and emotion. The identified symptoms were; 
physical and mental fatigue, muscle pain and symptoms associated with sympathetic 
nervous system activity. Illness beliefs centred around attribution of symptoms to 
disease, fear of exacerbating symptoms and concerns about lost performance. 
Behaviours tended to be avoidance of activity and fluctuation between activity and 
inactivity. Finally, associated emotions were identified as frustration and a reduction in
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the expression of anxiety and depression, despite the presence of symptoms typically 
associated with anxiety and depression. Surawy et al also attempted to explain the 
onset or precipitation of CFS in cognitive terms. They noted that certain aetiological 
factors were commonly observed in the history of CFS sufferers. Notably premorbid 
personality characteristics such as being “hard-working and achievement oriented” and 
a tendency to “bottle up” emotions. There was also a commonality about the events 
surrounding the onset of the illness, including chronic pressures to perform, life events 
and symptoms of acute illness. It is proposed by this paper that once the symptoms of 
fatigue are established they are perpetuated by various cognitive, behavioural, 
physiological and social factors (figure 1).
Insert Figure 1. About Here
Fry and Martin (26) reviewed the area and proposed a development of the model 
emphasising the role of cognitive processes in enhancing the perception of symptom 
severity and hence perpetuating illness beliefs. This model explicitly presents the 
theoretical inter-relationships of fatigue, mood and activity. See figure 2.
Insert Figure 2. About Here
This model was based on the evidence reviewed by Fiy and Martin that, in CFS, fatigue 
is neither peripheral; e.g. muscular or neuromuscular; nor central, e.g. 
neuroendocrinological. Rather, fatigue is viewed as being a cognitive phenomenon 
brought about due to perceptual distortions and resultant changes in affect.
Support for such a cognitive behavioural model of CFS might be extrapolated from the 
relative success of cognitive behavioural therapy (CBT) as a treatment or management 
of CFS. Such treatment aims to help the patient re-evaluate his understanding of his 
illness and find more appropriate behavioural methods for dealing with it. Sharpe,
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Hawton, Simkin et al (27) undertook a randomised control trial of CBT, in conjunction 
with standard medical care. Experimental subjects, who received 16 weekly sessions of 
CBT, showed significantly superior outcome measures with 73% achieving a 
satisfactory outcome at 12 months from the start of the study, compared to 27% of the 
control group. These results are supported by other similar studies, such as Wessley, 
David, Butler and Chalder (24) and Butler, Chalder, Ron and Wessley (28) but are not 
unequivocal (29, 30). Nevertheless, the report by the joint working party of the Royal 
Colleges (23) concludes that, as a treatment for CFS, CBT is a promising and cost- 
effective approach.
ACTIVITY IN CFS
As noted above, fatigue, illness beliefs and perceptions in CFS invariably impact on the 
sufferer’s behaviour, often resulting in decreased levels of day-to-day activity. Leisure 
pursuits, socialising and working are all frequently reported by CFS sufferers to be 
adversely affected by their illness. Many report avoiding activities due to anxiety about 
the consequences of “overdoing it” and, as a result, become deconditioned and more 
disabled. The subjects of rest, exercise and activity in CFS are surrounded by 
misconceptions and apprehensions for both the CFS patient and the clinician.
Rest
It is widely accepted that “rest”, particularly bed-rest, has many adverse consequences 
(31, 32). Saltin, Blomquist, Mitchel et al. (33) measured a 30% loss of aerobic capacity 
in just three weeks of bed-rest in trained individuals. The Royal Colleges report states 
that, from the available evidence, rest is contraindicated in CFS and very recently 
Sharpe and Wessely (34) emphatically titled a report on the issue; “Rest has no place in 
treating chronic fatigue”. However, for a variety of reasons, CFS sufferers may have 
treated their symptoms using long periods of bed-rest and over-sleeping. Vercoulen et 
al. (35) note that, although there was no difference in total sleeping time during the 
night between CFS patients and healthy subjects, the CFS group did spend more time 
asleep or resting during the day. The consequences of such behaviour is frequently 
deconditioning of muscles resulting in further fatigue.
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Exercise
There are many studies looking at exercise in CFS sufferers. A recent review by 
McCully, Sisto and Natelson (36) concluded that CFS patients were not significantly 
weaker nor more impaired than controls and that any reports of reduced exercise 
capacity in CFS is likely to be due to deconditioning as a result of the severe reductions 
in activity levels reported by CFS patients, as opposed to being part of an illness 
pathology.
There is literature which supports the use of graded exercise programmes in the 
treatment of CFS. For example Fulcher and White (37) tested the efficacy of a graded 
aerobic exercise programme compared to a relaxation and flexibility programme. They 
found fatigue, functional capacity and fitness were significantly improved after exercise 
relative to flexibility training.
It would generally appear from the literature that the exercise capacity of people with 
CFS is not significantly different from normal given their levels of activity and rest. 
Their perceptions of exercise, however, are quite different. Despite showing normal 
muscle physiology before and after exercise, their perception of effort during exercise 
has been shown to be significantly raised (38). There is evidence that these perceptions 
are centrally, rather than peripherally, mediated. Stokes, Cooper and Edwards (39) 
proposed that this central process involves a decreased threshold for sensations coming 
from peripheral receptors in the body. Fischler, Dendale, Michiels et al (40) note from 
their exercise study that CFS subjects are less tolerant and more avoidant of exercise. 
Interestingly, they also note that, in accordance with cognitive-behavioural models, 
perceptions of fatigue and effort are associated with increased functional disability in 
everyday living.
Taking the concept of altered effort perception in CFS a step further, Lawrie (41) argues 
that CFS could be viewed as primarily a disturbance in the perception of effort. He 
suggests that, from a neuropathological point of view rather than cognitive, the 
perception of effort in CFS is similar to a disturbance sometimes seen after brain 
lesions affecting motor areas. Hence patients with CFS would have to devote greater
18
attention to both motor output and sensory input during activity, resulting in increased 
perception of effort and decreased tolerance of activity.
Day-to-day Activity
Literature regarding day-to-day, functional activity levels in people with CFS is quite 
sparse. That which exists tends to concern itself with retrospective reports of activity 
levels or self reports of general functional ability.
Vercoulen, Swanink, Fennis, et al. (42) attempted to identify dimensions of CFS. 
Avoidance of activity and functional impairment in daily life were among those 
identified. They noted that 93% of patients reported severe impairment in daily life 
because of their complaints and only 4% did not report avoiding some degree of 
physical activity. Ray, Weir, Stewart et al. (43), using an illness management 
questionnaire, identified four main coping factors which predicted the variance of 
functional impairment, anxiety and depression. The coping factor “maintaining 
activity”, as would be expected, was found to correlate negatively with impairment and 
illness accommodation and correlate positively with anxiety and denial. However, as 
Ray et al. noted, a prospective design would be needed to clarify causality. Smets, 
Garssen, Bonke and de Haes (44) compared CFS patients with a variety of other groups 
including cancer patients, soldiers in training and junior doctors. They found that, on 
self-reported measures of physical activity, the CFS group reported significantly lower 
levels than the other groups and on measures of physical and mental fatigue, the CFS 
group had significantly higher scores than the other groups.
The three studies discussed above all used subjective, self-reporting methodologies. 
Studies which use objective measures to assess physical activity levels in CFS are rare. 
Fry and Martin (45) investigated the perceptions of children with CFS and their parents’ 
perceptions. They asked the children and their parents to report current activity levels 
and desired and expected future activity levels. In addition they used an ambulatory 
monitoring system to measure daily activity over a three day period. Interestingly, Fry 
and Martin found that self-reports of activity levels from both children with CFS and 
their parents under-estimated the actual level of activity. Also, despite the criteria that 
children with CFS should have fatigue severe enough to interfere with normal activities,
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there was no significant difference between the monitored levels of activity between the 
CFS and “normal” controls. It would appear, therefore, that retrospective self-reports of 
activity, as used previously (42,43,44), may not be true representations of the level of 
activity being undertaken by this population. Fry and Martin suggested that both the 
parents and the children in their study showed idiosyncratic cognitive processes which 
may play a role in the maintenance of the illness. These idiosyncratic cognitions may 
not be totally dissimilar in nature to those expressed regarding ability to exercise in 
CFS, i.e. although there is no objective evidence of pathophysiological reasons for 
being unable to exercise, CFS sufferers often report severe difficulties.
Despite using a self-report measure, Stone, Broderick, Porter, et al. (46) found activity 
levels in CFS sufferers to be similar to that of controls. Instead of using a retrospective 
measure, Stone et al used a momentary assessment technique in which subjects were 
randomly prompted by a palm-top computer to detail activity, fatigue and affect. In this 
way any possible retrospective biases and cognitive distortions could be minimised. A 
similar type of assessment technique was used by Packer, Foster and Brouwer (47) 
although they did not apply such technologically advanced equipment. Instead, they 
simply requested CFS subjects to record their primary activity each half hour for forty- 
eight hours. Each activity was also rated for fatigue, pain, enjoyment and perceived 
difficulty. Essentially, they reported that the CFS group rested more and spent less time 
in ‘productive activities’ i.e. work and household activities, than a healthy control 
group.
A recently published study by Vercoulen, Bazelmans, Swanink et al. (48) looked 
specifically at the efficacy of retrospective self-report measures of activity in CFS 
sufferers. They were able to confirm that simple self-observations made at the time 
correlated much more highly with actual measured activity levels than retrospective 
self-reports of general levels of activity. They also found a significant difference in 
objectively measured levels of activity between CFS subjects and a control group. This 
is in contrast to both Fry and Martin and Stone et al.’s findings above. Thus there exists 
some inconsistency in the research findings regarding day-to-day activity levels in CFS 
sufferers.
20
MOOD IN CFS
Depression and anxiety are by far the most common reported concurrent, diagnosable 
psychopathologies in CFS. It is estimated that approximately half of individuals seen in 
primary or specialist care with a diagnosis of CFS fulfil the criteria for an affective 
disorder, even disregarding the symptom of fatigue (49, 50). Only about one-quarter to 
one-third of people who fulfil the criteria for CFS do not fulfil any criteria for 
psychiatric disorders (49). However, this tells us nothing of causality.
Ray (21) notes that there are four main interpretations of the role of affective disorders 
in CFS:
1. The symptoms of CFS are a manifestation of psychological distress.
2. The rate of affective disorders in CFS may be inflated by the fact that the 
somatic complaints characterising it are also criteria for depression.
3. The affective disorders observed in CFS may result directly from 
pathological processes whose aetiology is distinct from that of a major affective 
disorder.
4. The affective state of patients with CFS is a reaction to the symptoms and 
consequences of CFS.
The joint report of the Royal Colleges (23) suggests that the shared origin theory 
(number 3) is most appealing and they dismiss the reverse causality theory (number 4) 
in most cases. This is due to the results from studies comparing CFS with other chronic 
and disabling illnesses which find CFS sufferers to have very elevated rates of 
psychiatric disorders. They acknowledge that anxiety and depression are the “strongest 
risk factors so far identified for CFS” but suggest that any simple equation with a 
psychiatric disorder (number 1) is also erroneous. It would appear that there can be a 
variety of mechanisms responsible for the mood status of an the individual with CFS 
and researchers and clinicians should bear this in mind.
Assessment of mood in CFS can be complicated by the prevalence of the many physical 
symptoms that the syndrome shares with depression, most notably fatigue. Many well
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validated and reliable measures of mood emphasise physical symptoms, for example, 
the Beck Depression Inventory (BDI) (51) contains questions relating to fatigue and 
health* What is more, it is possible that mood would vary in line with symptoms, so a 
one-off assessment using only a retrospective questionnaire might not yield as stable 
results as repeated measures of mood. This technique was used by Marshall, Watson, 
Steinberg et al (52) who repeated the Positive and Negative Affect Schedule (PANAS) 
each day of their study schedule and found lower levels of positive affect in their CFS 
group compared to a healthy control group.
Diurnal Patterns
On a momcnt-to-moment or day-to-day basis, mood is likely to subtly alter in response 
to minor changes in thoughts, behaviour, physiological or social events* These changes 
are unlikely to be clinically significant in themselves but will affect an individual’s 
quality of life and may, over the longer term, impact on overall state of mind.
Wood, Magnello and Sharpe (53) investigated the changes of perceived energy and 
mood in CFS on an hour to hour basis. They found significantly higher levels of 
negative affect for (he CFS group compared to a normal control group, using the 
Hospital Anxiety Depression Scale (Zigmond and Snaith, 1983) and visual analogue 
scales. They noted that energy levels and positive affect were highest in the late 
morning and lowest first thing in the morning and last thing at night.
As well as measuring activity, Stone et al. (46) examined fatigue and mood in CFS 
patients. They found changes in mood during the course of a day with subjects feeling
day. Unlike Wood et al. they did not observe significant differences in the overall level 
of positive and negative affect between the CFS and non-chronically ill control group.
Thus it would appear that mood in CFS sufferers has been documented to vary during 
the course of a day. However the few available papers on this topic do not clarify the 
nature, direction and extent of these variations.
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FATIGUE IN CFS
It is self-evident that a diagnosis of “chronic fatigue syndrome” can only be made in the 
presence of the key feature of prolonged, chronic fatigue. Sharpe et al. (2) speak of 
CFS as being “a syndrome characterised by fatigue as the principle symptom”. Fukuda 
et al. (1) note that the “chronic fatigue” within the syndrome is “defined as self-reported 
persistent or relapsing fatigue lasting for six or more consecutive months.”. According 
to a review of the literature (55) 100 per cent of CFS patients report symptoms of 
fatigue. The fatigue reported, however, is not constant and, like mood, it can be seen to 
vary over the course of a day.
Wood et al. (53) observed that CFS sufferers report significantly lower levels of 
physical and mental energy than either recovered CFS sufferers or a control group.
They note also that the normal diurnal pattern of energy is maintained, although at a 
lower overall level, with the highest level of energy being reported between waking and 
noon.
Consistent with Wood et al., Stone et al. (46) showed the CFS group to be more tired 
and less aroused than the control group. The fatigue experienced by the CFS group had 
a U-shaped function, being worse first thing in the morning and late in the evening.
According to Fry and Martins’ model (figure 2), fatigue not only varies diumally, but is 
affected by cognitions and activity. In their review, paper they argue that the fatigue in 
CFS is not purely a physiological phenomenon and cannot be explained purely in terms 
of an organic dysfunction, either peripheral or central. Instead they emphasise the role 
of beliefs and cognitions about desired and expected abilities and the subsequent impact 
these cognitions have on mood, and hence fatigue and activity levels.
SIMULTANEOUS INVESTIGATIONS OF ACTIVITY, FATIGUE AND MOOD
It would appear that there are few published studies investigating two or more of the 
above factors simultaneously in CFS. The paper by Stone et al. (46), mentioned
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frequently above, measured these variables simultaneously and used advanced statistics 
to ascertain the correlations between them. The details of the assessment tools used, 
however, were not made very clear and it does not appear that all the measures H.s&d 
were standardised. Despite this, the Stone et al. paper used a very elegant momentary 
assessment technique, as detailed in the activity section of this review. In this way 
moment to moment changes in mood, fatigue and activity were ascertained without the 
problems seen in other studies which have used retrospective, self-report measures.
Stone et al. noted that CFS subjects’ changes in affect over the day were independent of 
activity. There was no evidence that the CFS subjects’ experience of fatigue decreased 
their level of activity, though the researchers noted a modest degree of correspondence 
between fatigue and mood. Similarly, Wood et al. (53) noted that correlations between 
physical and mental energy and positive affect were significant, although correlations 
with negative affect were not. This relationship between energy and mood was noted to 
be the same for CFS patients as for the control subjects.
Stone et al also reported that level of activity or type of activity did not appear to be 
related to mood in chronic fatigue. Nevertheless, they noted that, in the normal 
population, social activities were associated with positive affect relative to work or 
occupational activities.
Morriss, Wearden and Battersby (56) measured fatigue and depression simultaneously 
in CFS and simply concluded that these measures were significantly elevated for their 
CFS group compared to control subjects.
CONCLUSION
The area of activity, fatigue and mood in CFS is an important one. Among other things, 
a better understanding of these factors could help CFS sufferers manage their symptoms 
more effectively. Much work has been completed in these areas which gives a degree 
of insight into how these variables might be affected in CFS. Furthermore, a model of 
CFS has been proposed by Fry and Martin which suggests the sorts of changes which
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might be expected in these factors in an individual suffering from CFS. To date, it 
appears that there has been no published research investigating this model more fully 
and thus it would seem appropriate to suggest that future research might ask questions 
based on examining aspects of such a theoretical model. In particular, the literature to 
date has not effectively explored the effects of CFS on normal day-to-day activity. As a 
result, the review of this area of the literature in particular could be said to be somewhat 
inconclusive.
Research into the areas of activity, fatigue and mood requires that researchers choose 
their methods carefully. As discussed above, certain types of self-report methodologies 
are apparently prone to yielding inaccurate results due to the cognitive idiosyncrasies of 
CFS patients. Ecological momentary assessment (EMA), in which subjects report their 
behaviour, perceptions or affect in the here and now, may be an effective way to avoid 
this problem. Stone and Shiffman (57) report EMA to be a more accurate and valid 
way to assess situational subjective states than retrospective self reports, but, when 
using momentary assessment techniques, a balance must be found between gathering 
huge amounts of raw data from subjects, thus requiring a lot of commitment from them, 
and losing valuable information due to coding and data aggregation at an early stage.
With regard to the assessment of activity, probably the most reliable method of 
approaching the area is by using objective measures to minimise self-report distortions. 
However, as Vercoulen et al (48) note, the next best option is to use a method which 
requires subjects to give “here and now” self-reports of activity as opposed to 
retrospective self-report.
In summary, there is no doubt that, over the years, many valuable studies have been 
completed looking at the various cognitive, behavioural and emotional aspects of CFS. 
Nevertheless, in the areas of activity, fatigue and mood, there are still many questions to 
be answered and future research in these areas needs to address these questions using 
carefully chosen, comprehensive methods.
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Thoughts
Behaviour
Consequences
“I am making myself ill” 
‘I must try to get better’
Avoid activity
Reduction in symptoms 
BUT
Failure to live up to standards
“I used to do more” 
‘1 should try harder’
Burst o f activity
Some achievement 
BUT
Increased symptoms and poor 
performance
Figure 1. Cognitive model o f the perpetuation o f CFS (Surawy et al., 1995)
Belief in physical 
illness and need to 
rest
Distorted perception o f how much was 
achieved premorbidly. Enhanced 
perception o f fatigue and pain
: DECONDITIONING :
Failure to reach desired goal. 
Expectation for future performance 
reduced
Discrepancy between 
expected and desired 
goal.
Belief in necessity to • 
achieve high standard. •
BURST OF 
ACTIVITY
DEPRESSIONFATIGUE
INACTIVITY
UNKNOWN CAUSAL AGENT
Figure 2. Cognitive model o f the perpetuation o f CFS (Fry and Martin, 1996)
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TITLE
An Exploration of Activity, Fatigue and Mood in Chronic
Fatigue Syndrome
SUMMARY
Chronic Fatigue Syndrome (CFS) is a debilitating illness. Despite a good deal of 
research in recent years, there is still little decisive evidence regarding its aetiology and 
research on treatment outcome is similarly inconclusive. The key symptom of CFS; 
fatigue, has previously been treated by prescribing rest for lengthy periods of time. 
Activity avoidance over a long time, however, will result in a deterioration of fitness, 
CFS symptoms subsequently occuring at progressively lower levels of exertion. CFS 
sufferers are noted to show high co-morbidity of psychiatric disorders, depression in 
particular. Levels of everyday activity in CFS sufferers, and their subsequent 
relationship to mood and the key symptom of fatigue, have not been studied in detail.
Research investigating the area of activity, fatigue and mood in CFS is sparse and only 
one detailed theoretical model of these relationships appears to exist, that of Fry and 
Martin (1996). There is no published research based on this model. Thus an 
observational study is proposed. The aim of this study will be to examine the above 
variables using a prospective momentary assessment technique and taking an objective 
measure of activity. As exploratory research, the initial proposal is simply to compare 
CFS subjects with ‘healthy’ matched controls, before then examining changes in the 
variables over the course of a day and briefly examining the relationships between 
measures.
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It is intended that subjects participating in this study will be recruited from CFS 
sufferers attending the clinic of Dr Todd (Consultant in Infectious Diseases), 
Monklands Hospital. The control group will be recruited from Health Board staff and 
families.
INTRODUCTION
Chronic Fatigue Syndrome (CFS) is the preferred term for a group of symptoms, the 
most prominent of which is a chronic and incapacitating fatigue for which no obvious 
organic cause can be found (Lietch, 1994). Other terms often used to denote the 
syndrome include: epidemic neuromyasthenia; myalgic encephalomyelitis (ME); post- 
viral fatigue syndrome; and "Royal Free" disease. Though the case definition for the 
diagnosis of CFS has been tightened in recent years, it remains, in practice, a diagnosis 
by exclusion when no other medical or psychological explanation for the symptoms can 
be found (Clements, 1993). The cause and mechanisms of CFS are unclear but, as 
noted in the report by the National Task Force on CFS (1994),
“Chronic fatigue syndromes often do not fit neatly into the conventional view that 
disease is either physical or psychological” (p. 2)
The report of a joint working group of the Royal Colleges of Physicians, Psychiatrists 
and General Practitioners (1996) noted as part of its conclusion:
“There is no evidence that infections have a primary causal role in the vast 
majority o f cases, although they appear to precipitate the disorder in some. Previous 
personality factors and premorbid distress appear to be more important than common 
viral infection per se. They may also play an important part in perpetuating disability.
“The evidence for structural or functional abnormalities o f brain or muscle or 
fo r a disturbance o f endocrine or immune function as primary aetiological factors in 
CFS is currently weak. ”(p. 37)
Hence the report emphasises and acknowledges the large part played by psychological 
factors in the symptomatology of CFS.
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CFS has no specific treatment. The interpretation of treatment outcome study results is 
hampered by the fact that a variety of diagnostic criteria exists to describe the 
syndrome. Pharmacotherapy, physiotherapy and psychotherapy, among others, have 
been studied as treatments ( the results are reviewed by, among others, Blondel and 
Shafran 1993), but it would appear that no single treatment provides a "cure" for CFS. 
However, evidence exists to suggest that cognitive behaviour therapy can provide some 
help in managing the symptoms.
In the normal population it is well documented that moderate activity can have 
beneficial effects on mood (see review by Yeung 1996). The rapid and detrimental 
effects of even short periods of bed rest on physical fitness have also long been 
documented (Asher, 1947; Greenleaf and Kozlowski, 1982). Individuals with CFS have 
frequently reported resting for many days or even months which is likely to cause major 
muscle wasting, deconditioning and loss of stamina. The result of this is that even 
minor, day to day activities may cause severe fatigue. It is felt that deconditioning and 
subsequent fatigue are likely to impact on mood. Whether it be cause or effect, co- 
morbid depression is noted to regularly accompany CFS (Wessley and Powell, 1989; 
David, 1991).
Fry and Martin (1996) emphasised the role of cognitive processes in enhancing the 
perception of symptom severity and hence perpetuating illness beliefs. Their model 
explicitly presents the theoretical inter-relationships of fatigue, mood and activity. See 
figure 1.
Insert Figure 1. About Here
This model is based on the review of evidence, which suggested that fatigue is neither 
peripheral, e.g. muscular or neuromuscular, nor central, e.g. neuroendocrinological. 
Rather, fatigue is viewed as being a cognitive phenomenon brought about due to
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perceptual distortions and resultant changes in affect. There has, to date, been no 
published study providing empirical evidence to support this model.
AIMS AND HYPOTHESES
This observational study aims to empirically explore key phenomena of CFS, 
particularly concentrating on altered behaviour, feelings of fatigue and low mood. It is 
proposed that the study will investigate objective levels of activity and prospective 
measures of fatigue and mood in a group of individuals referred to a CFS outpatient 
clinic. These measures will be compared with those of a group of ‘healthy* control 
subjects matched for age, sex and occupational activity at time of observation.
Research Questions
1. Does a difference exist between diagnosed CFS sufferers and matched controls in 
terms of:
i. day-to-day physical activity?
ii. fatigue?
iii. mood ?
2. Do differences in diurnal variation exist in CFS compared with matched controls in 
terms of:
i. day-to-day physical activity?
ii. fatigue?
iii. mood ?
3. What are the basic relationships between:
i. day-to-day physical activity?
ii. fatigue?
iii. mood ?
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PLAN OF INVESTIGATION
Design and Procedure
An observational study is proposed, in which high quality data will be collected in the 
form of objective and subjective measures. The design proposed, is intended to 
incorporate both within and between subjects elements. Activity, fatigue and mood 
measures in CFS and control groups will be quantitatively and qualitatively described, 
and differences between groups and at different times of the day will be described and 
discussed. Relationships between variables will be briefly examined.
Subjects and Recruitment
All subjects will be between the ages of 16 and 65. CFS patients will be recruited from 
a medical out-patient clinic by Dr Todd, who will confirm that all subjects have CFS 
which conforms to the American Centre for Disease Control criteria (Fukuda, Straus, 
Hickie et al., 1994). Patients who do not meet this research criteria will not be included 
in the study. Those patients interested in participating will be given an information 
sheet and have an opportunity to discuss the study with the researcher before signing a 
consent form.
Matched control subjects will be recruited from local Health Board staff and their 
families by word of mouth and notice boards if necessary. These control subjects will 
be provided with information as above.
Ten to fifteen subjects will be recruited to each group. The nature and time constraints 
of the study do not permit greater numbers.
Measurements
The following measures will be taken;
1. Mood will be measured using the Hospital Anxiety and Depression Scale - HADS 
(Zigmond and Snaith, 1983), which will be completed in order to give an approximate 
measure of affective disturbance at the time of first interview.
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2. Fatigue at the time of first interview will be measured using an appropriate, 
validated scale, such as the Fatigue Scale developed by Chalder, Berelowitz and 
Pawlikowska (1993).
3. A 48 hour objective measure of activity will be taken using an ambulatory 
monitoring system (‘Actiwatch’). This device is wire-free and is the size and weight of 
a standard wrist watch. It is manufactured by Cambridge Neurotechnology and is often 
used in clinical practice as a method of objectively assessing and monitoring behaviour.
4. Subjects will be asked to fill out a 48 hour record of activity, fatigue and mood. The 
exact nature of this diary will be decided by a pilot study. Ideally the diary should be 
filled in once every waking hour for the 48 hour sample. Activity could be coded to 
make this task easier. Fatigue and mood would theoretically be measured on an hourly 
basis using a very simple numerical scale.
Table 1 details the stages of subject participation
Insert Table 1. About Here
Settings and Equipment
It is intended that the subjects be interviewed at Dr Todd’s outpatient clinic, Monklands 
Hospital, preferably directly after their appointment with him thus avoiding the need for 
another journey to the hospital.
The equipment to be used will be the aforementioned questionnaires and Actiwatch 
with an appropriate computer package for the analysis of data collected using this 
instrument.
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Pilot of 48 Hour Diary
The diary will be piloted on a small group of individuals. In particular the layout and 
ease of completion of the 48 hour hourly record will be investigated as it is recognised 
that compliance and accuracy of recording will be influenced by subject perception of 
this tool. Open interviewing and subsequent discourse analysis could be used to this 
end.
Data Analysis
Each subject's data will be coded initially to ensure confidentiality and will be 
appropriately stored. Actiwatch data will be downloaded to the data storage and 
analysis programme on a computer in the Department of Psychological Medicine at 
Gartnavel Royal Hospital. The Actiwatch data will be corrected and coded for 
statistical purposes then transferred into SPSS for Windows spreadsheets for statistical 
analysis.
Data will be described and frequency distributions viewed to ensure appropriate 
statistical tests are chosen. The small numbers of subjects in each group and the types 
of measures taken, make it likely that non-parametric tests will be appropriate. Given 
the matched design, tests for related samples will generally be used. Statistical tests are 
likely to be two-tailed as predictions about direction of difference are not being made, 
the exception being when evaluating measures of fatigue, as these are predicted to be 
higher in CFS subjects.
PRACTICAL APPLICATIONS
It is hoped that this research will help provide information which will allow further 
understanding of the key factors of activity, fatigue and mood in CFS sufferers. Such a 
contribution would be expected to aid future study of this field by suggesting areas 
which might benefit from research of a more experimental type. It is also possible that 
implications for individual treatments could be generated by this research.
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TIMESCALES
Summer 1997 (July to September) - Collection of pilot study data and subsequent 
analysis will be completed with an appropriate number of subjects. During this time a 
full literature review will be completed and submitted. Any necessary changes to the 
study design resulting from the pilot or literature review will then be made. Also 
ethical approval from Monklands Ethics of Research Committee will be sought.
October 1997 to M arch 1998 - Data collection for the study proper. During this 
period it is expected that one day per week will be used solely to collect data.
M arch 1998 to June 1998 - Data analysis and first draft of project write-up will be 
completed.
ETHICAL APPROVAL
An ethics application based on this proposal will be submitted to the appropriate group. 
It is hoped that approval will be obtained with relative ease, given that this study uses 
wholly non-invasive and non-threatening techniques and adds the benefit to the 
participants of receiving personalised information on their symptoms and information 
on symptom management, which might not otherwise be provided. It is also considered 
that clinicians dealing with the individual cases might find the objective information 
gathered useful for planning intervention and monitoring treatment efficacy.
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goal
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achieve high standard
Figure 1: Cognitive model o f the perpetuation o f CFS (Fry and Martin, 1996)
45
Table 1: Summary o f participation stages
Prior to Participation The CFS patient attends the consultant and is given the "usual” 
assessment. If the patient fulfils the criteria, the consultant 
will provide information on study and study handout. The 
patient may then choose to discuss participation with 
researcher and may decide to sign the consent form and take 
part, in which case the initial meeting will take place then and 
there, or an arrangement will be made to meet with the subject 
at the out-patient clinic at a more convenient time.
Initial Meeting The subject will complete the HADS and Fatigue Scale. The 
protocol for use of the actiwatch and completion of the diary 
will be explained. Brief training for the rating and 
differentiation of mood and fatigue will be provided, problems 
or queries regarding procedure will be discussed, and a time 
agree for the return of the Actiwatch and diary.
48 Hour Period Subjects are then to go about their normal daily routines but 
record all their activities on an hourly basis using activity 
codes, and also rate their subjective level of fatigue and mood 
hourly also. The subject will then return the Actiwatch and 
diary to out-patients in the envelope provided
Feedback to Subjects All CFS subjects will then receive individual feedback on their 
mood, fatigue, activity and sleep measures (taken from diary 
and Actiwatch data). Patients will also be provided with an 
information pack designed to help them manage their CFS.
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An Exploration of Activity, Fatigue and Mood in Chronic
Fatigue Syndrome
Abstract - Previous studies o f  activity, fatigue and mood in chronic fatigue syndrome 
(CFS) have used diverse methodologies, often implementing retrospective, subjective 
measurements. Recent literature has suggested that such methods may not yield 
accurate representations o f  the experience o f  CFS. This study, therefore, attempts to 
apply scientific method to this complex and subjective field  by making use o f  an 
objective measure o f  activity in conjunction with concurrent, hourly self-ratings o f  
fatigue and mood states. The results indicate that the CFS subjects (n = 10) are 
significantly different from the healthy matched control group with regard to activity, 
fatigue and mood variables. Investigations o f diurnal patterns and interrelationships o f  
the measured variables, show that the CFS group possess a different pattern o f  daily 
activity and different variable interrelationships to those found in the matched controls. 
These findings, and their implications for future research, are discussed.
Keywords: Activity; Chronic fatigue syndrome; Fatigue; Methodology; Mood. 
INTRODUCTION
Chronic fatigue syndrome (CFS) is a condition of severe disabling fatigue. This fatigue 
has been suggested to result in decreased physical activity in CFS sufferers, thus leading 
to deconditioning (1).
In a number of studies, a positive relationship between physical activity and mood has 
been documented, as reviewed by Dubbert (2). Reports of an association between low 
levels of activity and fatigue also exist (3). Finally, there is much literature 
investigating CFS sufferers’ ability to exercise, as reviewed by McCully, Sisto and 
Natelson (4). However, explorations of day-to-day activity in CFS are scarce, 
particularly those which objectively measure “normal”, everyday activities.
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Fry and Martin (5) proposed a model of CFS in which the key symptoms of inactivity, 
perceptions of fatigue and low mood were described and their relationships suggested.
In most of the research into fatigue or mood in CFS, retrospective self-report 
methodologies have been used. Subjects are typically requested to rate their fatigue or 
mood over some reasonably long time period (for example, days or weeks). Stone, 
Broderick, Porter, et al.(6) noted that both passive and active distortions may operate in 
retrospective assessments of fatigue and mood. They therefore recommend that other 
assessment techniques, such as moment-to-moment reporting, are utilised. This type of 
assessment has the additional benefit of providing data on the variations of fatigue and 
mood over the course of a day. Stone et al (6) noted that CFS subjects reported 
increased fatigue in the morning and evening and improving mood over the course of 
the day. Woods, Magnello and Sharpe (7) noted maximum energy levels and positive 
mood in CFS subjects between 10 and 12 o’clock in the morning. These two studies 
noted similar variation of fatigue over the day, with fatigue being greatest first thing in 
the morning and in the evening. These studies did not document similar diurnal 
patterns of mood.
Fry and Martin (8) and Vercoulen, Bazelmans, Swanink et al (9) suggested that 
cognitive distortions also occur in the reporting of activity levels in CFS. Both groups 
noted that actual activity levels were significantly different from perceived or reported 
activity levels. These are the only studies to date to have measured objective levels of 
day-to-day activity in CFS. Unfortunately, the results of these two studies are somewhat 
contradictory. Fry and Martin found that 19 children with CFS showed no significant 
difference in activity level compared to age and sex matched “healthy” controls, 
whereas Vercoulen et al reported their adult CFS group (n = 51) had significantly lower 
recorded levels of activity than age and sex matched “healthy” controls. Both studies 
used similar activity monitors worn on the ankle. This method of monitoring activity 
has been shown to provide highly reliable data (10), and close correlations with energy 
expenditure have been reported (11). It is particularly suited to non-intrusive 
monitoring of day-to-day activity levels as monitors are small and can be worn nearly 
all of the time. In the Fry and Martin study (8) activity was recorded over three days
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and in the Vercoulen et al. study (9), recordings were made over 12 days. Fry and 
Martin did not use measures of raw activity data in their comparison, rather they 
reported each subject’s percentage of sampled epochs over a specific activity threshold- 
In contrast, Vercoulen et al. reported a mean activity value for each subject. These 
methodological differences could have accentuated the discrepant results. Finally, the 
discrepancy in findings between these two studies may have been due to a difference in 
the behaviour of children with CFS to that of adults with CFS.
A more detailed review of the literature surrounding this area can be found in Verity 
(1998) - (previous section of this thesis). Based on this review, the current study aimed 
to examine the key variables of; activity, fatigue and mood in CFS. For the reasons 
discussed above, this study used an objective measure of activity in conjunction with a 
prospective, momentary assessment technique, similar to that used by Stone et al. (6).
This study attempted to answer the following questions: (a) What are the differences in 
prospective fatigue and mood ratings between CFS subjects and matched “healthy” 
control subjects? It was expected that fatigue ratings would be greater in the CFS 
group, and it was more tentatively hypothesised that mood would be lower in CFS 
subjects, (b) Is objectively measured physical activity lower in subjects with CFS than 
in controls? It was thought that this was likely to be the case, (c) Are there differences 
between tire CFS and control groups in levels of physical activity and prospective 
ratings of fatigue and mood at different times of the day? Fatigue was expected to be 
higher in the morning and evening, although the direction of variations in activity and 
mood over time were not predicted, (d) What are the relationships between activity, 
fatigue and mood? The extent and directions o f relationships were not predicted, but 
instead were to be explored.
METHOD
Subjects
The study was of matched-pairs design. Ten CFS patients (5 male and 5 female) were 
recruited from a  medical out-patient clinic by the consultant in infectious diseases (ID)
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dealing with their case. For inclusion, subjects were confirmed by the consultant to be 
suffering from CFS, using the research criteria defined by the American Centre for 
Disease Control (12) (A summary of this criteria can be viewed in Appendix 4.2). For 
inclusion, subjects were also to be aged >15 to <65 years old. The average age in the 
CFS group was 36.5 years old (± 8.9years). Subjects reported having been symptomatic 
for an average of 48.5 months (range 6-196 months ± 56.5). Each of the 10 CFS 
subjects was matched with a healthy control subject for age, sex and occupational 
activity at time of recording (table 1 gives descriptive details of the two groups).
Insert Table 1. About Here
Instrumentation
Wrist actigraphy was produced using the AW2 model of Actiwatch manufactured by 
Cambridge Neurotechnology Ltd. This device was considered superior to those used in 
previous studies due to its small size (27 x 26 x 9mm), ultra light weight (16g) and 
design making it as comfortable and unobtrusive to wear as a wrist watch. The 
Actiwatch utilises an accelerometer to monitor the occurrence and degree of motion. 
The piezo-electric sensor integrates the degree and speed of motion to produce the 
activity counts that are recorded. Each Actiwatch had been programmed with a 
calibration coefficient to normalise data between watches. The recording epoch length 
was set to 0.5 minutes, which allowed 48 hours of actigraphy to be recorded. This was 
considered the optimum length of time for recording activity, as subjects also had to 
complete an hourly diary of fatigue and mood. Subjects were required to wear the 
Actiwatch on their non-dominant wrist throughout the recording period to ensure 
consistency. The AW2 Actiwatch model had an event marker button which, when 
pressed by the subject, marked the time and date on the record. The watch was only to 
be removed when bathing to prevent damage by water.
Stored data, including the subject’s personal code, start and stop time, sampling 
interval, actigraphic counts and details of events marked, were downloaded onto an 
IBM compatible personal computer and analysed. Using the rythmwatch/ sleepwatch
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programme, a total activity score for each hour per subject could be then calculated.
This was transferred directly onto a Windows Excel spreadsheet. It was then corrected 
for the short periods of missing data which related to the watch being removed for 
showers etc.. The data, having been corrected by averaging activity over the rest of the 
hour, were subsequently transferred from the Excel spreadsheet onto the statistics 
package - Statistics Package for Social Sciences (SPSS).
Measures
Before the 48 hour activity recording was started, subjects completed questionnaires for 
the purpose of describing group characteristics:
1. Hospital Anxiety Depression Scale (HADS) - Zigmond and Snaith( 13). This 
14 item scale assessed both anxiety and depression and was felt to be appropriate for 
assessment of this population as it has limited interference from physical illnesses.
2. The Fatigue Scale - Chalder, Berelowitz, Pawlikowska, et al. (14). This 18 
item scale was used to assess both physical and mental aspects of fatigue.
48 Hour Diary
During the period of actigraph recording, subjects kept a brief hourly record of their 
activity, mood and fatigue. Each time they completed the diary they were asked to 
event mark their actigraph record so degree of adherence to the hourly diary could be 
ascertained. This was found to be satisfactory in both CFS and control groups.
Because of the necessity for reasonable compliance to instructions and minimal diary 
interference in normal day-to-day activities, three different types of activity diary were 
piloted on a group of eight healthy subjects. The three types were:
1. Hourly diary, activity coded using numbers 1 to 8 and an activity key;
2. Hourly diary, activity not coded, instead space left to detail activity;
3. Diary to be filled in retrospectively only three times a day, activity not coded. 
Of the eight pilot subjects, six expressed a strong preference for the hourly coded form 
of the diary. Suggestions for clarification of instructions regarding coding of activities 
and wording of instructions were taken into account in the final form of the diary. The 
codes used are presented in table 2. (The diary used can be viewed in Appendix 4.3).
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Insert Table 2. About Here
Mood and fatigue ratings were to be made at the same time as activity was noted down. 
For these, a 1 to 5 Likert scale was used and a key given for the meaning of each 
number as it pertained to each variable. For example, for fatigue, 1 = “not fatigued” 
and 5 = “exhausted”. Training was given at the initial meeting between subject and 
researcher to ensure that the subject understood and could distinguish between the 
variables.
Procedure
Out-patients received an information leaflet (Appendix 4.4) about the CFS study and 
were asked by the ID consultant if they were interested in taking part. Those interested 
discussed the protocol with the researcher and signed a standard consent form 
(Appendix 4.5). Subjects then completed the HADS and Fatigue Scale and were given 
further information on wearing the Actiwatch and completion of the 48-hour diary. The 
Actiwatch was programmed to start recording from 6pm that night. Due to the timing 
of the ID clinic the 48 hour period for CFS subjects always started at 6pm on a 
Thursday. In return for their participation, the CFS subjects received individual 
feedback and an information pack on managing chronic fatigue and related problems. 
This was based on information provided in Chalder (15). Permission was gained from 
the author to use the information in this way.
Control subjects were recruited by word of mouth from Health Service personnel and 
their families, the procedure above was followed. Six control subjects were recorded 
over the same period (Thursday 6pm to Saturday 6pm). The other four were recorded 
over the weekend so as to minimise the effects of occupational activity on their record 
as they were matched with non-working CFS subjects.
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Statistical Analysis
Statistical analysis was carried out using SPSS for Windows (Version 6.1). All 
statistical tests were performed two-tailed at the 5% level of significance, with the 
exception of fatigue measures which were tested one-tailed.
The Actiwatch data were aggregated by subject to the level required for the analysis. 
That is, hourly totals and forty-eight hour totals were calculated for each subject.
Frequency distributions were examined and a non-normal distribution was found. Thus 
the Wilcoxon matched-pairs signed-ranks test was used to compare between the groups 
on measures of activity, fatigue and mood. Hourly self-ratings of fatigue and mood were 
transformed to mean ratings for each 6 hour portion of the day per subject. Friedman 
tests were used to compare differences in activity, mood and fatigue ratings at these 
different times. Correlations were computed between the main variables using 
Spearman’s rank correlations.
RESULTS
Group Differences in Initial Questionnaire Results
As can be seen in table 3, the CFS group reported significantly higher levels of anxiety 
(p = 0.012, z = -2.505) and depression (p = 0.005, z = -2.829), assessed by the HADS, 
than the matched control group. The CFS group’s depression score remained 
significantly higher when scores from the statement ‘I feel as if I am slowed down’, 
were removed from their HADS results.
As was predicted, the CFS group also reported significantly higher levels of fatigue (as 
assessed by the Fatigue Scale).
Insert Table 3. About Here
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Group Differences in Individual Total Activity
The quality and type of data generated by this study’s methodology meant that there 
were several possible ways in which it could be aggregated for analysis. The most 
global method was to use a total activity count for each subject. Figure 1 provides a 
graphical representation of total activity count, during the 48 hour recording period, for 
each individual, displayed in matched pairs.
Insert Figure I. About Here
A two-tailed Wilcoxon matched-pairs signed-ranks test showed no significant 
difference in activity when aggregated into individual totals (p = 0.093, z = -1.682). 
Inspection of the graph revealed a great deal of variability in total activity counts in 
both the CFS and control groups.
Group Differences in Hourly Activity
An alternative, and more specific, method by which activity counts may be aggregated 
is on an hourly basis. This method makes better use of the quality of data collected. 
Total activity level per hour was found to be significantly lower for the CFS group than 
for the control group (p < 0.001, z = -3.846). It can be seen from table 4 that the 
median hourly activity of the CFS group was approximately 25% less than that of the 
control group.
Insert Table 4. About Here
Hourly levels of objective activity can be viewed in the first graph of figure 2. It can be 
seen that the control group showed higher peaks of activity and, although the groups 
became active at about the same time of day, the control group seemed to maintain 
activity for longer and at a higher level. This was particularly apparent in the afternoon
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(hours 18 to 24 and 42 to 48 correspond to the period midday to 6pm) and evening 
(hours 1 to 6 and 25 to 31 are the period of 7pm to midnight). (Activity levels of each 
matched pair over the 48 hour period can be viewed in Appendix 4.6)
Insert Figure 2. About Here
Group Differences in Reported Hourly Fatigue, Mood and Rest 
Aggregation of the hourly self-report data on fatigue and mood, to give global, 
individual totals, was felt to be inappropriate as the effects of diurnal variation would 
be lost. Thus hourly levels of fatigue and mood, aggregated by group, were analysed.
A graphical representation of these measures can be viewed in figure 2.
As expected, mean hourly ratings of fatigue were significantly higher in the CFS group 
(p = 0.002, z = -2.803), with ratings of these subjects typically twice as high as those of 
the controls. Mean hourly ratings of mood were also found to be significantly greater in 
the CFS group (p = 0.005, z = -2.803), with higher mood scores relating to increased 
low mood.
Finally, in the coded activity diary, CFS subjects reported spending significantly more 
time resting and sleeping during the 48 hour recording period than the control subjects 
(p = 0.018, z = -2.374). Detailed comparisons of sleep patterns in these groups will 
form the basis of a future report. (See Appendix 4.7 for future use of data set).
Insert Table 5. About Here
Diurnal Variation in Activity, Fatigue and Mood
Having explored the differences between CFS subjects and matched controls in terms of 
global and hourly activity, fatigue and mood. The question of altered diurnal patterns 
of these variables was subsequently addressed. The 48 hour recording period was,
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therefore, divided into six-hour sections. Morning was defined as 7am to midday; 
afternoon as 1pm to 6pm; and evening as 7pm to midnight. Because most subjects were 
asleep during the 1 am to 6am period, this time was not included in analysis. As the 
data from each time period were taken from both the days recorded, a total of 12 data 
points were available for analysis.
Total group hourly activity and mean group hourly self-ratings of fatigue and mood 
were calculated. The difference between the groups on activity, fatigue and mood 
variables was evaluated using a Friedman’s one way analysis of variance (ANOVA) 
comparing the three different periods.
The CFS subjects activity was found to be significantly different from that of the 
eontrol group (p < 0.001, Xr2== 16.666, d f=2). Post-hoc testing using the Wilcoxon 
matched-pairs signed-ranks test revealed that there were significant differences in 
activity between all three time periods. See table 6.
Insert Table 6. About Here
Analysis of differences between the group ratings for both fatigue and mood showed no 
significant difference over time (fatigue; p = 0.272, Xr2 = 2.600, df=2:  mood; p = 
0.067, Xr2 = 5.400, df=  2).
Intercorrelations Between Activity, Fatigue and Mood
Having investigated daily variations in the patterns of activity, fatigue and mood, the 
final research question to be addressed was that of intercorrelations of these variables*
In order to achieve this it was decided to again maximise the quality of the data by 
completing analysis of hourly aggregations of activity, fatigue and mood. Spearman’s 
rank correlations were used to explore the interrelationships of these key variables.
In the control group, a significant negative correlation was found between activity and 
fatigue (p = 0.003, r = -0.463). The relationships between mood and activity and mood
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and fatigue, in the control group, were not found to be significant (p = 0.389, r =0.144; 
p = 0.757, r = 0.052, respectively).
The correlation between activity and fatigue, found to be highly significant in the 
control group, was not significant in the CFS group (p = 0.311, r = 0.174). However, 
the correlation between mood and fatigue ratings were highly significant (p < 0.001, r =
0.572). The was no significant correlation found between mood and activity in the CFS 
group (p = 0.150, r = 0.245).
Insert Table 7. About Here
Stepwise Multiple Regression
The correlations completed above were simple, bi-variate analyses of the data. They 
could not explain the possible predictive interrelationships of these variables. Thus, the 
next logical step was to attempt to examine which variables predicted fatigue in the two 
groups. This was achieved using step-wise multiple regression. Fatigue was taken as 
the dependent variable and mood and activity were entered as the independent 
variables. A dummy variable of time code, which represented the time periods in which 
data were recorded, was also entered as an independent variable.
For the CFS group, step-wise multiple regression demonstrated that only mood was a 
significant predictor of fatigue (p = 0.002, F (i} 34) = 10.754, Adj R2 = 0.218, p = 0.490). 
This indicates that self rated mood explained a significant amount of the variance of 
fatigue. However, the objective measure of activity did not explain a significant 
proportion of the variance of fatigue.
For the control group, step-wise multiple regression demonstrated that only the 
objective measure of hourly activity emerged as a significant predictor of fatigue (p <
0.001, F (i( 36) = 15.296, Adj R2 = 0.279, p = -0.546). The relationship between activity 
and fatigue was inverse in nature.
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Thus these analyses confirmed the impression given by the simple bi-variate analyses.
DISCUSSION
Level o f  Physical Activity and Rest
The present study demonstrated that the CFS group had a lower hourly level of activity 
and also reported spending more hours resting, than the healthy matched controls.
These findings support some past findings regarding activity and rest in CFS (9,16). 
However, the significant difference between the CFS and control groups’ activity levels 
was dependent on the method of data aggregation. This suggests that the method by 
which objective measures of activity are aggregated, is important When activity was 
chunked into total individual scores, as oppose to total hourly scores, the difference 
between the CFS and control groups was not found to be significant. The only two 
previous studies of objective activity in CFS (8,9) apparently used just one overall 
activity score per subject Fry and Martin (8), who had a smaller subject group (n = 19), 
found no significant difference, whereas Vercoulen et al. (9), using a subject group of 
51, noted a significant difference (p < 0.05). The current study’s finding of no 
significant difference when the data is aggregated into total per subject, may be due to 
low numbers of subjects, although an alternative explanation might be that CFS affects 
certain individual’s behaviour more than others. It can be noted in figure 1 that there is 
a very wide variation in total activity scores, with several CFS subjects showing a 
slightly higher level of activity over the 48 hour period than their matched control.
Mood and Fatigue
In both the retrospective questionnaires completed initially (the fatigue scale and the 
HADS), and in the hourly self-ratings of mood and fatigue, significant differences were 
noted between the groups. As predicted, the CFS subjects were very much more 
fatigued than the control group. There was also a highly significant difference between 
the groups on all measures of mood, with the CFS group being significantly lower in 
mood (hourly self-ratings) and exhibiting more depressed and anxious symptomatology 
(HADS scores). Vercoulen et al (17) concluded that low levels of physical activity in
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their CFS patients were not attributable to depressive symptomatology. This may also 
be the case with the CFS subjects in this study.
Variation in Activity
It can be seen from the first graph in figure 2 that, during the morning period of both of 
the recorded days, both the CFS and control groups’ total hourly activity levels 
increased rapidly and appeared relatively similar. The CFS subjects’ activity peaked in 
the morning on both days; 10 am on the first day (a Friday) and midday on the second 
day (a Saturday), whereas the peak for the control group appeared more variable.
During the afternoon time period the total hourly activity recorded became more 
dissimilar, as the control group’s total activity continued to increase on the first 
afternoon recorded, whereas the CFS group’s appeared to decrease after the morning 
peak. The control group’s activity on the second afternoon decreased only slightly 
relative to that of the CFS group. Finally, during both evening periods recorded, the 
CFS group could be observed to have had a much lower total activity than the control 
group.
These observations were confirmed by statistical analysis comparing differences in the 
two groups’ activity at different times of day. It could be seen that the CFS group was 
most different from the control group during the evening compared to the morning, with 
the comparison between afternoon and morning also being very significant. The 
comparison between afternoon and evening was also significant but to a lesser degree. 
Thus the CFS group had an overall pattern of activity which was only similar to that of 
the control group during the morning. The activity level then seemed to tail off after 
midday and became progressively more different from that of the control group. There 
appear to be no other studies to date which have observed this pattern of activity in CFS 
patients.
However, a note of caution must be added to the activity findings in general, due to the 
fact that four of the control subjects were recorded over the weekend. This was done in 
order to minimise the effects of occupational activity, as they were matched with non­
working CFS subjects, however, it may have resulted in a slightly different pattern of
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activity than would be expected for the non-working, healthy population during the 
week. For example, rising later in the morning and staying active later into the evening.
Variation in Fatigue and Mood Self-Ratings
The second and third graphs in figure 2 plot the hourly mean ratings of mood and 
fatigue in the CFS and control groups. It was observed that mood appeared relatively 
constant for both groups, the CFS group having a higher hourly rating (i.e. lower mood) 
than the control group. Although on the first morning recorded, mood rating in the CFS 
group seemed to start high (i.e. increased reports of low mood) and decrease slightly 
during the day, this pattern was not observed on the second morning. Fatigue ratings 
remained reasonably constant over the whole day in the CFS group. This pattern of 
fatigue was slightly different from that of the control group. It was noted that the 
control group’s fatigue ratings remained stable through most of the day before sharply 
increasing Late in the evening.
Statistical analysis of these variations, however, found no significant difference in the 
patterns of either mood or fatigue in the CFS group compared to controls. This is in 
contrast to the findings of Stone et al. (6) that diurnal patterns of fatigue and affect were 
different in CFS subjects compared to the control group. However, the findings from 
this study are similar to those of Wood et al (7). They reported that the pattern of 
diurnal energy, which might be presumed to be inversely related to fatigue, in CFS 
subjects was similar to that of controls.
Intercorrelations and Multiple Regression o f  Activity, Fatigue and Mood 
The results from the Spearman’s rank correlations and step-wise multiple regression 
were interesting in that they demonstrated differences between the groups in the 
relationships found between the variables. Two particular differences were noted:
1. The relationship between fatigue and mood.
In the CFS group, a strong positive correlation was noted between self-rated fatigue and 
mood. Regression analysis demonstrated that only self-ratings of mood could 
significantly predict self-ratings of fatigue. Fatigue and mood ratings were made 
simultaneously at the end of each hour when subjects were asked to rate how they felt at
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that very moment. The positive relationship found suggested that, for the CFS group, 
mood and fatigue were very closely coupled, with low mood predicting increased 
fatigue. An alternative explanation might be that the CFS subjects had difficulties 
differentiating these states, and thus the data from the mood and fatigue scales were 
essentially measurements of the same thing. However, as all subjects were trained 
regarding the distinguishing of feelings of fatigue from those of low mood, the latter 
explanation is perhaps less likely to be the case.
Positive correlation between momentary reports of mood and fatigue has been 
previously noted by Stone et al (6). However, Woods et al. (7,18) found no 
relationship between low mood and fatigue in either CFS subjects or healthy volunteers. 
It is likely that the results of this study are more robust than previous similar studies, 
given the methodology used and the strength of correlation found.
2. The relationship between activity and fatigue.
A strong negative correlation was found between objective hourly activity and fatigue 
ratings in the control group only. As fatigue was to be rated at the end of each hour, it 
is logical to assume that increased activity was leading to decreased fatigue in this 
group. This assumption was supported by the regression analysis. There was no 
significant relationship between fatigue and activity in the CFS group. However, the 
relationship found in the control group is supported, to an extent, in the literature on 
exercise and arousal (19), although, of course, the measured activity was general, day- 
to-day activity rather than exercising per se.
CONCLUSION
In summary, this study has taken a new approach to looking at activity, fatigue and 
mood in CFS. Activity was measured objectively, a method only used in two previous 
studies of this patient group. Also, mood and fatigue were rated by subjects on an 
momentary, prospective basis, eveiy hour. Again, this is a method which has been used 
very infrequently in the past, despite evidence to suggest retrospective self-ratings made 
by CFS sufferers may be affected by cognitive distortions (8).
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The group of CFS subjects in the present study showed significantly more 
psychopathology, in the form of raised HADS scores and higher hourly self-ratings of 
low mood, than the control group. As expected, they also reported higher levels of 
fatigue. Their activity level was seen to be significantly lower than that of the control 
group when analysed on an hourly basis. Analysis confirmed that during the afternoon 
and evening periods of the day, the CFS subjects showed a different activity pattern to 
that of the controls. This difference in the activity patterns of CFS patients has not been 
noted previously and may reflect an important underlying aspect of the syndrome. The 
relationships between activity, fatigue and mood were found to be different in the CFS 
group compared to the control group. Specifically the strong relationship that exists 
between mood and fatigue, found only in the CFS group, may suggest a pathological 
process. As might the lack of the negative relationship between activity and fatigue, 
which was found to be very strong in the matched control sample. These findings might 
benefit from further investigation in the future.
The analysis of hourly data, rather than aggregated global data, is thought to be an 
important methodological feature of this study. This approach appears to maximise the 
value of the data and allows micro- rather than macro-presentations to be observed. It 
is possible that aggregating this type of data would introduce unnecessary error as it 
might even out hourly variation which is in itself an important feature. These 
observations may also be important for clinicians seeking to understand an individual’s 
presentation. Perhaps asking a CFS sufferer for a general or global report of symptoms 
and behaviour would lead to misrepresentation of the more specific variations found on 
a momentary basis.
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Table I: Age, sex and duration o f illness in CFS group and matched control group
CFS Group Control
Group
Number 10 10
Female:Male 5:5 5:5
Age (mean ±SD) 36.5 (± 8.9) 33.4 (± 7.9)
Age range 24-53 27-53
Duration CFS (months, mean ±SD) 48.5 (± 56.5) N/A
Table 2: Activity codes used in 48-hour diary
ACTIVITY CODE
sleeping 0
resting - sitting or lying down, relaxing e.g. reading, watching TV, chatting 
with friends at home
1
active in or about the house e.g. personal grooming, dressing, cooking, 
eating, housework, DIY, gardening
2
active ‘housework’ outside the house e.g. shopping, driving etc. related to 
normal housekeeping
3
light occupational activities e.g. at work - mainly sitting, and work related 
activities, e.g. driving to work
4
heavy occupational activities e.g. at work - standing, lifting, physical jobs 5
exercise - activities in which the intention is to increase stamina, fitness or 
health e.g. walking, running, exercise classes, muscle toning exercises
6
socialising outside house e.g. at friend’s, cinema, cafe, restaurant, and other 
leisure activities e.g. travelling, sight seeing, visiting a museum
7
other or not sure - if vou are unsure which code is correct for the activitv 
you were engaged in, please write what you were doing in the space 
provided on the activity sheet and code it 8
8
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Table 3: Group differences in initial questionnaire results using the Wilcoxon
Matched-pairs Signed-ranks Test (2-tailed except for fatigue scale)
CFS Group (mean 
±SD, median)
Control Group 
(mean ±SD, median)
probability z-score
HADS-Anxiety 12.9 ±4.7, 13.0 4.9 ± 2.7, 4.5 0.0122 -2.5054
HADS-Depression 10.0 ±3.8, 10.0 1.8 ±2.2, 1.0 0.0047 -2.8290
(total)
HADS-Depression 7.6 ±3.4, 8.0 1.0 ± 1.6, 0.5 0.0048 -2.8233
(statement removed)
Fatigue Scale 13.5 ±0.8, 14.0 4.1 ±4.4, 2.5 0.0038 -2.6703
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Figure 1: Total activity during the 48 hour period: displayed in matched pairs
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Table 4: Group differences in hourly activity using the Wilcoxon Matched-pairs
Signed-ranks Test (2-tailed test)
CFS Group Control Group probability z-score
Mean hourly activity 141488.0 176991.7
Standard deviation ± 104064.9 ± 115356.4 0.0002 -3.8462
Median hourly activity 157735.5 211439.0
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Figure 2: Variation in hourly activity, fatigue and mood over 48 hour period
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Table 5: Group differences in reported hourly fatigue, mood and rest; analysed using 
the Wilcoxon Matched-pairs Signed-ranks Test(2-tailed except for fatigue rating)
CFS Group 
(mean ±SD)
Control Group 
(mean ±SD)
Probability z-score
Mean hourly rating - 3.2 ±0.9 1.6 ±0.3 0.0025 -2.8031
fatigue
Mean hourly rating - 2.2 ±0.9 1.2 ±0.3 0.0051 -2.8031
mood
Hours reported resting 10.4 ±4.1 6.5 ±3.1 0.0463 -1.9928
Hours reported resting 28.8 ±4.8 22.6 ±4.1 0.0176 -2.3736
plus sleeping
Table 6: Post-hoc Wilcoxon matched-pairs signed-ranks testing o f activity difference 
between groups, during morning, afternoon and evening.
Morning Afternoon
Afternoon p = 0.0060, z = -2.7456
Evening p = 0.0022, z = -3.0594 p = 0.0342, z = -2.1181
Table 7: Intercorrelations o f hourly activity and fatigue and mood ratings
CFS group Control group
Activity Fatigue Activity Fatigue
Fatigue p = 0.311, 
r = 0.1738
p = 0.003, 
r = -0.4629
Mood p = 0.150, 
r = 0.2449
p = 0.000,
r = 0.5720
p = 0.389, 
r = 0.1440
p = 0.757, 
r = 0.0518
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CLINICAL CASE RESEARCH STUDY 1 (abstract)
Avoidance of Trauma Exposure in the Treatment of Post- 
Traumatic Stress Disorder
Target Journal: Journal o f Behaviour Therapy and Experimental Psychiatry 
(see Appendix 5 for Instructions to Authors)
Abstract
Prolonged exposure to memories o f the traumatic event is generally considered to be an 
essential component in the treatment o f  post-traumatic stress disorder (PTSD). 
Unfortunately, some patients may find  it difficult to engage in this type o f  treatment.
This study investigates the efficacy o f  treatment which addresses only secondary 
depression and anxiety in an individual with PTSD following rape. Prolonged 
exposure to memories o f  the trauma were avoided during treatment. Instead, general 
cognitive-behavioural treatment for anxiety and depression was used. The results 
indicate that, fo r  the individual concerned, avoidance o f  prolonged exposure in 
treatment did not prevent some improvement in the anxiety and depression symptoms 
that were secondary to PTSD. However, the PTSD phenomenology itself was not seen 
to change substantially.
Keywords: Anxiety, Avoidance, Depression, Exposure, Post-Traumatic Stress Disorder.
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CLINICAL CASE RESEARCH STUDY 2 (abstract)
Collaborative Empiricism in the Treatment of Chronic Pain
A Case Study
Target Journal: Journal o f  Pain and Symptom Management 
(see Appendix 6 for Instructions to Authors)
Abstract
Chronic pain, and its accompanying beliefs and behaviours, may be associated with 
anxiety, depression and low self-efficacy. This paper discusses the process o f treatment 
for an individual with chronic pain. In this case study, collaborative empiricism was 
used, with the patient and therapist working together to gain a better understanding o f  
the patient’s unique experience. A warm, empathic therapeutic relationship, together 
with appropriate structure and support in treatment, allowed the patient to implement 
changes in behaviour which consequently altered her pain experience, anxiety and 
depression.
Key-words: Anxiety, Chronic Pain, Collaborative Empiricism, Depression, Self- 
Efficacy.
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CLINICAL CASE RESEARCH STUDY 3 (abstract)
Deterioration of cognitive function in an individual with Velo- 
Cardio-Facial Syndrome and associated psychosis
Target Journal: Neurocase 
(see Appendix 7 fo r Instructions to Authors)
Abstract
Velo-cardio-facial syndrome (VCFS) is a common multiple anomaly syndrome 
generally resulting from deletions within chromosome band 22qll. The incidence o f  
schizophrenia and other psychiatric illnesses is increased in VCFS relative to the 
general population. Very little literature exists regarding cognitive function in this 
syndrome, in particular changes in intellectual ability over the course o f  time are rarely 
discussed. This report explores the neuropsychological profile a young woman with 
VCFS and chronic schizophrenia. The results o f this current assessment are compared 
with those from past assessments o f  this individual and the changes in cognitive 
function over time are discussed.
Keywords: Cognitive Function, Neuropsychological Assessment, Pharmacotherapy, 
Schizophrenia, Velo-Cardio-Facial Syndrome.
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A PPE N D IX  1
SUBMISSION NOTES FOR CLINICAL PSYCHOLOGY FORUM
Clinical Psychology Forum
Clinical Psychology Forum is designed to serve as a discussion forum for any issues of 
relevance to clinical psychologists. The editorial collective welcomes brief articles, 
reports of events, correspondence, book reviews and announcements.
Notes for contributors
Articles of 1000-2000 words are welcomed. Shorter articles can be published sooner. 
Send two copies of your contribution, typed and double spaced. Contributors are asked 
to keep tables to a minimum, to ensure that all references are complete and accurate, 
and to give a word count. News of Branches and Special Groups is especially welcome.
Language: contributors are asked to use language which is psychologically descriptive 
rather than medical and to avoid using devaluing terminology; i.e. avoid clustering 
terminology like “the elderly” or medical jargon like “person with schizophrenia”. If 
you find yourself using quotation marks around words of dubious meaning, please use a 
different word.
Articles submitted to Forum will be sent to members of the Editorial Collective for 
refereeing. They will then communicate directly with the authors.
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A PPE N D IX  2
INSTRUCTIONS TO AUTHORS FOR THE JOURNAL OF PSYCHOSOMATIC 
RESEARCH
Journal of Psychosomatic Research
Affiliated to the International College of Psychosomatic Medicine 
Instructions to Authors
Papers must be written in English. They will be acknowledged on receipt, and then 
reviewed. The decision on acceptance will usually be conveyed to the authors within 
two months.
Full Length Papers. Full length research papers will not normally be more than 4000 
words in length and will preferably be shorter. Submission of a paper to the Journal o f  
Psychosomatic Research will be held to imply that it represents original research not 
previously published (except in the form of an abstract or preliminary report), that it is 
not being considered for publication elsewhere, and that if accepted by the Journal o f  
Psychosomatic Research it will not be published elsewhere in the same form in any 
language without the consent of the Publisher. Major papers of topical content will be 
given priority in publication.
Short Reports. The Journal welcomes short reports, which may be either preliminary 
communications or brief accounts of original research. Case reports will be published 
only if they illustrate important issues. The text must not exceed 1500 words. Short 
reports will normally be published more quickly than full length papers.
Editorials. The Editors welcome suggestions for editorials which give personal and 
topical views on subjects within the Journal’s area of interest. They should not normally 
exceed 1500 words.
Review Articles. Review papers are normally 4000-5000 words. Authors are advised to 
consult one of the Editors with an outline before submitting a review.
Letters to the Editors. These normally refer to articles previously published in the 
Journal. The Editors are also willing to consider letters on subjects of direct relevance 
to the Journal's interest.
Book Reviews. These are normally submitted by the Book Review Editors, but they 
welcome suggestions of books for review.
Other Papers. The Editors welcome suggestions for other types of papers, such as 
conference reports, accounts of major research in progress and interviews with senior 
research workers. These should not be submitted without prior consultation.
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Manuscript Requirements
Manuscripts should conform to the uniform requirements known as the 'Vancouver 
style' (International Committee of Medical Journal Editors. Uniform requirements for 
manuscripts submitted to biomedical journals. N Engl J Med 1997; 336:309-315). The 
Editors and Referees attach considerable importance to a succinct and lucid prose style 
and well organized tables. Authors whose native language is not English are advised to 
seek help before submission. Statistical procedures should be clearly explained.
Manuscripts should be typed with wide margins, double-spaced on one side of standard 
A4 or 8.5" x 11" paper. The format should be as follows:
Title page. This should contain (a) the title of the article; (b) a short running head; (c) 
name of department where the work was conducted; (d) names of the each author with 
highest academic degree; (e) name, address, phone and fax of author responsible for 
correspondence and to whom requests for reprints should be addressed; (f) up to six 
keywords should be listed in alphabetical order after the abstract. These terms should 
optimally characterize the paper.
Abstract. This should not exceed 150 words.
Text. This should be divided into sections with main headings: Introduction, Method, 
Results and Discussion. Accepted papers will usually be between 2000 and 4000 words 
in length.
Acknowledgments. These must include mention of any source of funding outside the 
basic funding of the host institution.
References. These should be numbered consecutively in the text in the order in which 
they are first mentioned and be so denoted in the list. Their form should be that adopted 
by the US National Library of Medicine, as used in the Index Medicus and as 
recognized in Uniform Requirements:
1. Ingham JC, Miller P McC. Self-referral to primary care: symptoms and social factors. 
J Psychosomatic Res 1986;30:49-56.
2. Berkenbosch F. Corticotrophin-releasing factor and catecholamines: a study on their 
role in stress-induced immunomodulation. In: Schneiderman N, McCabe P, Baum, A, 
eds. Perspectives in behavioral medicine. Hillsdale, New Jersey: Erlbaum 1992:73-91.
Tables. Each should be on a separate sheet, numbered consecutively in Roman 
numerals.
Figures A glossy photograph or clear ink drawing of each should be sent. Each figure 
should be numbered on the back and the top should be marked. A photocopy should be 
attached to each copy of the manuscript. Captions should be on a separate sheet. The 
number of illustrations should be kept to a minimum. Color illustrations are not 
normally acceptable. Authors may be asked to support the costs of color reproduction.
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Letters to the Editors. Letters should not exceed 1000 words and, where appropriate, 
must begin with the reference to the published article about which the author is 
commenting.
Authors are encouraged to submit a computer disk (5.25” or 3.5" HD/DD disk) 
containing the final version of their papers along with the final manuscript to the 
editorial office. Please send disk only after manuscript has been accepted for 
publication. Please observe the following criteria: (1) Specify what software was used, 
including which release (e.g., WordPerfect 6.0); (2) Specify what computer was used 
(either IBM compatible PC or Apple Macintosh); (3) Include both the text file 
and ASCH file on the disk; (4) The file should be single-spaced and should use the 
wrap-around end-of-line feature (i.e., no returns at the end of each line). All textual 
elements should begin flush left, no paragraph indents. Place two returns after each 
element such as title, headings, paragraphs, figure and table callouts, etc.; (5) Keep a 
back-up disk for reference and safety.
Submission O f Manuscripts
Each manuscript should be accompanied by a covering letter in which: (1) all authors 
must give signed consent to publication; (2) relationship of the submitted paper to any 
other published, submitted or proposed papers reporting the same study is explained. 
Three high quality copies are required. Authors from the United Kingdom and the 
remainder of Europe should send manuscripts to DR. RICHARD MAYOU, University 
Department of Psychiatry, Wameford Hospital, Wameford Road, Oxford 0X3 7JX, 
UK. Authors from North America, Australia and the Far East should send manuscripts 
to DR. COLIN SHAPIRO, Department of Psychiatry, University of Toronto, The 
Toronto Hospital, ECW-3D, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8; 
(416) 603-5388; FAX (416) 603-5036.
Rejected manuscripts and correspondence will be destroyed six months after receipt. 
Proofs and Reprints
The corresponding author will receive page proofs for checking. Corrections must be 
restricted to printing errors. Any other alterations may be charged to the author.
Reprints may be ordered when the proofs are returned.
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A P PE N D IX  3
FORMAT BASED ON APPLICATION FOR A MINI-PROJECT GRANT IN HEALTH
SERVICES RESEARCH (SOHHD)
1.1 Applicants -  names and addresses including the names of co-workers 
and supervisor (s) if known.
1.2 Title -  no more than 15 words.
1.3 Summary -  No more than 300 words, including a reference to where 
the study will be carried out.
1.4 Introduction -  of less than 600 words summarising previous work in 
the field, drawing attention to gaps in present knowledge and stating 
how the project will add to knowledge and understanding.
1.5 Aims and hypothesis to be tested -  these should wherever possible be 
stated as a list of questions to which answers will be sought.
1.6 Plan of investigation -  consisting of a statement of the practical 
details of how it is proposed to obtain answers to the questions posed.
The proposal should contain information on Research Methods and 
Design i.e.
1.6.1 Subjects -  a brief statement of inclusion and exclusion criteria and 
anticipated number of participants.
1.6.2 Measures -  a brief explanation of interviews/ observations/ rating 
scales etc. to be employed, including references where appropriate.
1.6.3 Design and Procedure -  a brief explanation of the overall 
experimental design with reference to comparisons to be made, 
control populations, timing of measurements, etc. A summary chart 
may be helpful to explain the research process.
1.6.4 Settings and equipment -  a statement on the location(s) to be used and 
resources or equipment which will be employed (if any).
1.6.5 Data analysis -  a brief explanation of how data will be collated, stored 
and analysed.
1.7 Practical applications -  the applicants should state the practical use to 
which the research findings could be put.
1.8 Timescales -  the proposed starting date and duration of the project.
1.9 Ethical approval -  stating whether this is necessary and, if so, whether 
it has been obtained.
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A PPEN D IX  4.1
INSTRUCTIONS TO AUTHORS FOR THE JOURNAL OF PSYCHOSOMATIC 
RESEARCH
Journal of Psychosomatic Research
Affiliated to the International College of Psychosomatic Medicine 
Instructions to Authors
Papers must be written in English. They will be acknowledged on receipt, and then 
reviewed. The decision on acceptance will usually be conveyed to the authors within 
two months.
Full Length Papers. Full length research papers will not normally be more than 4000 
words in length and will preferably be shorter. Submission of a paper to the Journal o f  
Psychosomatic Research will be held to imply that it represents original research not 
previously published (except in the form of an abstract or preliminary report), that it is 
not being considered for publication elsewhere, and that if accepted by the Journal o f  
Psychosomatic Research it will not be published elsewhere in the same form in any 
language without the consent of the Publisher. Major papers of topical content will be 
given priority in publication.
Short Reports. The Journal welcomes short reports, which may be either preliminary 
communications or brief accounts of original research. Case reports will be published 
only if they illustrate important issues. The text must not exceed 1500 words. Short 
reports will normally be published more quickly than full length papers.
Editorials. The Editors welcome suggestions for editorials which give personal and 
topical views on subjects within the Journal's area of interest. They should not normally 
exceed 1500 words.
Review Articles. Review papers are normally 4000-5000 words. Authors are advised to 
consult one of the Editors with an outline before submitting a review.
Letters to the Editors. These normally refer to articles previously published in the 
Journal. The Editors are also willing to consider letters on subjects of direct relevance 
to the Journal's interest.
Book Reviews. These are normally submitted by the Book Review Editors, but they 
welcome suggestions of books for review.
Other Papers. The Editors welcome suggestions for other types of papers, such as 
conference reports, accounts of major research in progress and interviews with senior 
research workers. These should not be submitted without prior consultation.
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Manuscript Requirements
Manuscripts should conform to the uniform requirements known as the 'Vancouver 
style' (International Committee of Medical Journal Editors. Uniform requirements for 
manuscripts submitted to biomedical journals. N Engl J Med 1997; 336:309-315). The 
Editors and Referees attach considerable importance to a succinct and lucid prose style 
and well organized tables. Authors whose native language is not English are advised to 
seek help before submission. Statistical procedures should be clearly explained.
Manuscripts should be typed with wide margins, double-spaced on one side of standard 
A4 or 8.5" x 11" paper. The format should be as follows:
Title page. This should contain (a) the title of the article; (b) a short running head; (c) 
name of department where the work was conducted; (d) names of the each author with 
highest academic degree; (e) name, address, phone and fax of author responsible for 
correspondence and to whom requests for reprints should be addressed; (f) up to six 
keywords should be listed in alphabetical order after the abstract. These terms should 
optimally characterize the paper.
Abstract. This should not exceed 150 words.
Text. This should be divided into sections with main headings: Introduction, Method, 
Results and Discussion. Accepted papers will usually be between 2000 and 4000 words 
in length.
Acknowledgments. These must include mention of any source of funding outside the 
basic funding of the host institution.
References. These should be numbered consecutively in the text in the order in which 
they are first mentioned and be so denoted in the list. Their form should be that adopted 
by the US National Library of Medicine, as used in the Index Medicus and as 
recognized in Uniform Requirements:
1. Ingham JC, Miller P McC. Self-referral to primary care: symptoms and social factors. 
J Psychosomatic Res 1986;30:49-56.
2. Berkenbosch F. Corticotrophin-releasing factor and catecholamines: a study on their 
role in stress-induced immunomodulation. In: Schneiderman N, McCabe P, Baum, A, 
eds. Perspectives in behavioral medicine. Hillsdale, New Jersey: Erlbaum 1992:73-91.
Tables. Each should be on a separate sheet, numbered consecutively in Roman 
numerals.
Figures A glossy photograph or clear ink drawing of each should be sent. Each figure 
should be numbered on the back and the top should be marked. A photocopy should be 
attached to each copy of the manuscript. Captions should be on a separate sheet. The 
number of illustrations should be kept to a minimum. Color illustrations are not 
normally acceptable. Authors may be asked to support the costs of color reproduction.
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Letters to the Editors. Letters should not exceed 1000 words and, where appropriate, 
must begin with the reference to the published article about which the author is 
commenting.
Authors are encouraged to submit a computer disk (5.25" or 3.5" HD/DD disk) 
containing the final version of their papers along with the final manuscript to the 
editorial office. Please send disk only after manuscript has been accepted for 
publication. Please observe the following criteria: (1) Specify what software was used, 
including which release (e.g., WordPerfect 6.0); (2) Specify what computer was used 
(either IBM compatible PC or Apple Macintosh); (3) Include both the text file 
and ASCD file on the disk; (4) The file should be single-spaced and should use the 
wrap-around end-of-line feature (i.e., no returns at the end of each line). All textual 
elements should begin flush left, no paragraph indents. Place two returns after each 
element such as title, headings, paragraphs, figure and table callouts, etc.; (5) Keep a 
back-up disk for reference and safety.
Submission O f Manuscripts
Each manuscript should be accompanied by a covering letter in which: (1) all authors 
must give signed consent to publication; (2) relationship of the submitted paper to any 
other published, submitted or proposed papers reporting the same study is explained. 
Three high quality copies are required. Authors from the United Kingdom and the 
remainder of Europe should send manuscripts to DR. RICHARD MAYOU, University 
Department of Psychiatry, Wameford Hospital, Wameford Road, Oxford 0X3 7JX, 
UK. Authors from North America, Australia and the Far East should send manuscripts 
to DR. COLIN SHAPIRO, Department of Psychiatry, University of Toronto, The 
Toronto Hospital, ECW-3D, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8; 
(416) 603-5388; FAX (416) 603-5036.
Rejected manuscripts and correspondence will be destroyed six months after receipt. 
Proofs and Reprints
The corresponding author will receive page proofs for checking. Corrections must be 
restricted to printing errors. Any other alterations may be charged to the author.
Reprints may be ordered when the proofs are returned.
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A PPEN D IX  4.2
DIAGNOSTIC CRITERIA FOR CHRONIC FATIGUE SYNDROME 
Fukuda, Straus, Hickie et al. (1994)____________________________
I. Clinically evaluate cases o f prolonged fatigue by:
A. History and physical examination;
B. Mental status examination;
C. Tests:
1. Screening lab tests: e.g. CBC, ESR, ALT, total protein, albumin;
2. Additional tests as clinically indicated to exclude other diagnoses.
Exclude case if  another cause 
for chronic fatigue is found.
B. Classify as idiopathic 
fatigue if  fatigue severity 
or symptom criteria for 
chronic fatigue syndrome 
are not met.
Subgroup research cases further as needed by optional parameters 
such as epidemiologic or laboratory features o f interest.
II. Classify case as either chronic fatigue syndrome or idiopathic 
chronic fatigue if  fatigue persists or relapses for >6 months.
III. Subgroup research cases by the presence or absence o f the 
following essential parameters:
A. Comorbid conditions;
B. Current level of fatigue;
C. Duration o f fatigue;
D. Current level o f physical function.
A. Classify as chronic fatigue syndrome if:
a. Criteria for severity o f fatigue are met, and
b. Four or more o f the following symptoms are 
present for > 6 months:
1) impaired memory or concentration, 2) sore throat, 3) 
tender cervical or auxiliary lymph nodes, 4) muscle pain, 
5) multi-joint pain, 6) new headaches, 7) unrefreashing 
sleep, 8) post-exertion malaise.
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A PPEN D IX  4.3
DAILY ACTIVITY DIARY
Nam e______________   Date of Birth _ _ ___________
DAILY INSTRUCTIONS
The actiwatch that you have been given is set to start recording at 6.00pm Thursday. 
You will notice that the activity diary also starts at 6.00pm. Therefore your first entry 
to your diary should be at 7.00pm and each hour after that for the next 48 hours, except 
when you are asleep.
You should try to carry the daily activity diary with you at all times and complete it 
each hour, if possible. Each time you complete the diary please press down firmly on 
the “marker” button on the actiwatch. This allows me to know the exact time at which 
you are filling in the diary.
If for any reason you cannot complete the diary one hour, or if you forget, please think 
back to what you were doing at that time. If you can clearly remember what you were 
doing and exactly how you felt, then fill it in. However, if you are not totally sure. 
leave it blank. It will be more useful to have a half-filled but totally accurate dairy than 
one in which lots of guesses are made.
When filling in the daily activity diary, please refer to the codes below. If you are not 
sure what code is correct for a particular activity please write the activity in the space 
provided and code it as 8.
ACTIVITY CODE
sleeping 0
resting - sitting or lying down, relaxing e.g. reading, watching TV, chatting 
with friends at home
1
active in or about the house e.g. personal grooming, dressing, cooking, 
eating, housework, DIY, gardening, working at home
2
active ‘housework’ outside the house e.g. shopping, driving etc. related to 
normal housekeeping
3
light occupational activities e.g. at work - mainly sitting, and work related 
activities, e.g. driving to work
4
heavy occupational activities e.g. at work - standing, lifting, physical jobs 5
exercise - activities in which the main intention is to increase stamina, 
fitness or health e.g. walking, running, exercise classes, etc.
6
socialising outside house e.g. at friend’s, cinema, cafe, restaurant, and other 
leisure activities e.g. travelling, sight seeing, visiting a museum
7
other or not sure - if vou are unsure which code is correct for the activity 
you were engaged in, please write what you were doing in the space 
provided on the activity sheet and code it 8
8
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In the MOOD box, please think about how your mood was at the end of that hour and 
place a number between 1 and 5 , where;
1 = fine
2 = a little low in mood
3 = quite low in mood
4 = very low in mood
5 = very depressed indeed
In the FATIGUE box, please think about how tired and fatigued you feel at the end of 
the hour. Place a number between 1 and 5 in the box, where;
1 = not fatigued
2 = a little fatigued
3 = quite fatigued
4 = very fatigued
5 = exhausted
When you turn out the light to go to sleep at night and on getting up in the morning, 
please press the actiwatch “marker” button firmly.
N.B. Although the actiwatch is water-resistant in theory, past experience has resulted in 
a recommendation that it be removed rather than allowed to get wet. Please take it off 
before showering, bathing etc.. Also, please remember to put it back on as soon as 
possible once dry.
START OF 48 HOUR DIARY
u u u
Day 1 - 6pm to midnight
Date
HOUR ACTIVITY 
CODE 
(for 8 give 
details in 
last column)
M
O
O
D
F
A
T
I
G
U
E
W ritten details of activity - if coded 8.
6pm - 7
7 -8
8 -9
90
9- 10
10-11
11 -
midnight
Day 2 - full 24 hours Date
HOUR ACTIVITY 
CODE 
(for 8 give 
details in last 
column)
M
O
O
D
F
A
T
I
G
U
E
W ritten details of activity - if coded 8.
midnight - 
lam
1 -2
2 -3
3 -4
4 -5
5 -6
6 -7
7 -8
8 -9
9- 10
10-11
11 -
midday
12 midday 
- 1pm
1pm - 2
2 -3
3 -4
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4 -5
5 -6
6 -7
001r-
8 -9
9 - 1 0
10-11
11 -
midnight
Day 3 - midnight to 6pm
Date
HOUR ACTIVITY 
CODE 
(for 8 give 
details in 
last column)
M
O
O
D
F
A
T
I
G
U
E
W ritten details of activity - if coded 8.
midnight - 
lam
1 -2
2 -3
3 -4
4 -5
5 -6
6 -7
7 -8
8 -9
9 -  10
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10-11
11 -
midday
12 midday 
- 1pm
1pm - 2
2 -3
3 -4
4 -5
5 -6
If you have finished, please take a little time to think back over your hourly record of 
activity, fatigue and mood. Did you have any problems filling this in? YES / NO 
(please circle)
Also, did you have any problems using the actiwatch, such as remembering to wear it or 
using the marker button? YES / NO (please circle)
If YES, would it be all right for Kirsten Verity to contact you to discuss these problems? 
YES/NO
Now please remove the actiwatch and place it, and this diary, in the envelope provided. 
Please keep this envelope in a safe place until it is convenient for you to drop it off or 
for Kirsten Verity to pick it up. If you have problems with this, or any other part of the 
project, please contact Kirsten Verity on 01236 746 117 as soon as possible.
Thank you very much for taking the time to take part.
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A PPEN D IX  4.4
INFORMATION SHEET FOR PATIENTS/ VOLUNTEERS IN A CLINICAL
RESEARCH STUDY
PROJECT TITLE: ACTIVITY, FATIGUE AND MOOD IN CHRONIC FATIGUE 
SYNDROME
Patient/Volunteer Summary
You are being invited to take part in a study of Chronic Fatigue Syndrome (also called 
M.E. or Post-Viral Fatigue Syndrome). This study aims to find out how people with 
Chronic Fatigue Syndrome deal with their symptoms from one day to the next. In 
particular it will look at how normal, day to day activities make people with Chronic 
Fatigue Syndrome feel, both physically and mentally.
There is not very much known about how Chronic Fatigue Syndrome affects a person’s 
behaviour and feelings. By taking part in this study you will be helping the medical 
profession understand more about Chronic Fatigue Syndrome which might in turn help 
them develop alternative ways to treat it.
Your participation in this study is totally voluntary. W hether or not you decide to 
take part will have no effect on your treatment at all. You can withdraw from the 
study at any time without giving a reason and this will have no effect on your 
normal care.
W hat will happen if you agree to take part?
1. You will be asked to meet with Kirsten Verity, the researcher, at Dr Todd’s out 
patient clinic. At the first meeting she will go over the details o f  the study again and 
answer any questions you might have about it. She will also ask you to fill in a consent 
form and two or three short questionnaires about how you feel at that time. This will 
probably take about half an hour.
2. You will then be shown an "actiwatch". This is a little device, about the same size as 
a wrist watch. You wear it on your wrist and it records how much activity you do. You 
will be asked to wear it fo r  48 hours.
3. During the 48 hours that you are wearing the actiwatch, you will also be asked to fill 
in a diary o f  what activities you are doing and how you feel at the time. This is the 
difficult bit because we ask that you fill in the diary on the hour, fo r every hour that you 
are awake during this time. The good news is that the diary is very easy to fill in and 
should not take more than 30 seconds each time you have to fill it in.
4. At the end o f  the 48 hour period you will be required to come back to the hospital to 
return the actiwatch. With your permission, Kirsten will contact you a few days later to 
ask you i f  you had any difficulties doing the above.
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5. In order that you get something from helping us in this study, Kirsten will prepare an 
individual report for each person taking part in the study from their results. This will 
be sent to you after completion o f the study and will have details about your level o f  
activity, your mood and your sleep pattern. You will also be given an information pack 
about Chronic Fatigue Syndrome with suggestions about things that you can do which 
have helped other sufferers to cope with it in the past.
If you would like to take part in the study you will need to fill in a consent form. You 
will be offered one by Kirsten Verity. Please read the form carefully, it should be 
signed by both yourself and the researcher.
If you are unsure whether you wish to take part in the study please feel free to discuss 
with Kirsten any questions or concerns you have about participating. You are under no 
obligation to take part in the study after talking to her.
Thank you for your help.
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A PPEN D IX  4.5
PATIENT OR VOLUNTEER CONSENT TO PARTICIPATE IN RESEARCH
STUDY
Project Title: Activity, Fatigue and Mood in Chronic Fatigue Syndrome
■ You should have been given a complete explanation of the research in which you are 
being invited to take part, including details of the procedures and treatment you 
would undergo as part of the study.
■ You should have had the opportunity to ask questions.
■ You should have received the Information Sheet on the study which has been 
approved by Lanarkshire Health Board Ethics of Research Committee, which you 
should have read and should keep.
■ There is no obligation to take part in the study and you need not give any reason if 
you do not wish to take part in the study.
■ You may withdraw from the study at any time without the need to give a reason and 
without any effect on your normal care.
Consent
I ..............................................................................  (name in block capitals)
of
.................................................................................................... (address in block capitals)
agree to take part in this research project, the nature, purpose and possible 
consequences of which have been described to me
b y ................................................................................................. (name in block capitals)
If necessary, I may/may not (delete as applicable) be contacted at home by the 
researcher.
My telephone number i s .............................................
Subject signature
.........................................................................................................  dated ..................
Researcher signature
dated
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A PPEN D IX  4.6
MATCHED PAIRS - HOURLY ACTIVITY OVER 48 HOUR RECORDING PERIOD 
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CFS subject  control
60000
50000
V 40000
30000
S  20000
10000
o oco CD CT> in
CM
oo
CM
Tt-co r»co CO CDif
time
PAIR 2
70000
60000
w 50000 
c
o 40000
30000
re 20000 r.
10000
r-coo co <T> CMCM mCM M-CO o co■M- CDCO
time
PAIR 3
80000
70000
600004c 500003
8
£g»
?
40000
30000
20000
10000 -
o CO o CD•M"co O inCM COCM e'­en CDCO
time
97
PAIR 4
60000
50000
40000
30000
20000
10000
CMO CO CD 05 in CO
CM
o■«* CO CD
time
PAIR 5
70000
60000
0  50000 
c
o 40000 o
I '  30000 
"  20000
10000
coo CD 05 CM
CM
in
CM
CO
CM
O■M- CO CD
time
PAIR 6
50000
45000
40000
w 35000
§ 30000 o
£  25000 
|  20000 
" 15000 
10000 
5000 
0
98
PAIR 7
70000
60000
50000
o 40000
30000
20000
10000
c o i o f - ~ a > T - r o m f - a > c o  m  CD t -
CM CM CM CM CO
c o  m  O )
c o  c o  c o  c o
c o  i n  h -
time
PAIR 8
100000
90000
80000
70000
§ 60000 o
£  50000 
£
£  40000
30000
20000
10000
•<— c o  i n  c d c o  m  cr> t -  c o
CM CM
i n  c -  O )  ■»-
CM CM CM CO
c o  m  o c o  i n  s
time
PAIR 9
60000
50000
J240000
,30000
co 2 0 0 0 0
10000
c o  m  h ~  o> c o  i n  ct> t-  < o  m  O )  t-
CM CM CM CM CM CO
c o  i n  r - -  c n
c o  c o  c o  c o
c o  m  c -  ■m- tj-
time
99
ac
tiv
ity
 
co
un
ts
PAIR 10
45000
40000
35000
30000
25000
20000
15000
10000
5000
n  in  n  a CO VO o ■ * - f O i o h ~ o > T - c o i o
C M < \ l < N C \ I C \ I C 0 C0 C0
r— cx>(O n  ^ co in i^ -'f  't  ^
time
100
APPENDIX 4.7
FURTHER USE OF STUDY DATA
The preceding Major Research Project Paper reported the analysis of data pertaining to 
a specific set of questions. These research questions should be viewed as the first level 
of an exploratory procedure. The nature of data collection and the experimental design 
used have yielded supplementary data on sleep patterns as well as reported levels of 
sleepiness and perceived levels of effort in CFS subjects. Furthermore, because of the 
momentary assessment method used in conjunction with objective activity measures, 
the data can be considered as ideal for formal time series analysis, such as ITSACOR. 
Such analyses are planned for completion at a later date and, like the previous paper, 
the results are expected to make an important contribution to this relatively under- 
researched area.
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